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Macrophages participate in two main biological functions; they actively participate in 
apoptotic body removal and are involved in pathogen elimination. Interestingly, lysosomal 
membrane trafficking events have been shown to be vital for both processes. Ingestion of large 
extracellular particles, such as apoptotic bodies, requires the fusion of lysosomal membranes 
with the plasma membrane (i.e. lysosomal exocytosis) in order to provide excess membrane for 
the formation of plasmalemmal pseudopod necessary for phagosome sealing and, consequently, 
particle ingestion. Conversely, pathogen elimination by macrophages involves the trafficking of 
the ingested pathogens to lysosomes for degradation. Here I identified Mucolipin TRP channel 1 
(TRPML1) as the key lysosomal Ca
2+
 channel regulating both lysosomal trafficking events in 
macrophages. Both lysosomal exocytosis and particle ingestion are inhibited by synthetic 
TRPML1 blocker and are defective in macrophages isolated from TRPML1 knockout mice. 
Additionally, TRPML1 overexpression and TRPML1 agonists induce both lysosomal exocytosis 
and particle uptake. By using time-lapse confocal imaging I found that particle binding induces 
the production of lysosomal PI(3,5)P2 in order to trigger TRPML1-mediated lysosomal Ca
2+
 
release specifically at the site of particle uptake. This then promotes the fusion of TRPML1-
containg lysosomal membranes with the plasma membrane at the site of particle uptake through 
lysosomal exocytosis.  Thus, phagocytic ingestion of large particles activates a phosphoinositide- 
and Ca
2+
- dependent exocytosis pathway in order to provide the membrane necessary for 
xxi 
 
pseudopod extension. In correlation with this, accumulation of apoptotic cells was observed in 
various tissues obtained from TRPML1 knockout mice, suggesting defective clearance of 
apoptotic cells in vivo. Moreover, I observed that bacteria elimination is inhibited by synthetic 
TRPML1 blocker and is defective in macrophages isolated from TRPML1 knockout mice. Time-
lapse confocal imaging showed that the fusion of bacteria-containing phagosomes with the 
lysosomes is defective in macrophages lacking TRPML1 activity. Collectively, I have showed 
that TRPML1 regulates various lysosomal membrane trafficking events within macrophages by 
releasing lysosomal calcium into the cytoplasm and providing the calcium necessary for 










1. Overview of lysosomal dynamics and function 
1.1 Lysosomes as the degradation and nutrient-sensing center 
Lysosomes are acidic compartments in mammalian cells that are primarily responsible 
for the breakdown of various biomaterials such as membranes, proteins, polysaccharides, and 
complex lipids into their respective building blocks: amino acids, monosaccharaides, fatty acids, 
or nucleotides (Kornfeld and Mellman 1989; Braulke and Bonifacino 2009).  Hence, since their 
discovery by Christian Duve in 1955, lysosomes have been viewed as the cell’s degradation 
center (Luzio, Pryor et al. 2007).  Each mammalian cell has several hundred lysosomes, all 
heterogeneous in size (about 200-1000 nm) and morphology, which collectively constitute 
approximately 5% of the cell volume (Mellman 1989). As single membrane-bounded vesicles, 
lysosomes are filled with 50 different types of hydrolases, such as lipases, proteases, and 
glycosidases, which effectively convert proteins and complex lipids into their building block 
molecules (Schulze, Kolter et al. 2009; Kolter and Sandhoff 2010).  The functions of most 
lysosomal hydrolytic enzymes require an acidic lumen, which is established and maintained by 
V-ATPase proton pumps located on the perimeter membrane (Mellman, Fuchs et al. 1986). To 
protect the perimeter membrane and its resident membrane proteins from degradation, the inner 
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leaflet of the lysosomal membrane is coated with a polysaccharide layer called the glycocalyx 
(Neiss 1984).  
The biomaterials destined for degradation are delivered to lysosomes through 
endocytic/phagocytic and autophagic pathways (Fig. 1.1). Endocytosis or phagocytosis of 
extracellular particles and plasma membrane proteins begins with the invagination of the plasma 
membrane to form an endocytic vesicle, which then undergo a  series of maturation process to 
first become early endosomes, then late endosomes, and eventually lysosomes (Huotari and 
Helenius 2011). In the late endosomes, cargo and substrates destined for degradation are sorted 
into intraluminal vesicles, called multi-vesicular bodies (MVBs), via the endosomal sorting 
complexes required for transport (ESCRT) system. Mature late endosomes containing MVBs 
then fuse with lysosomes to become endolysosome hybrids to mediate the degradation (Fig. 1.1).  
In parallel with endocytosis, dysfunctional intracellular organelles and misfolded proteins reach 
lysosomes through the autophagic pathway (Fig. 1.1). Double membrane-bound autophagosomes 
fuse directly with lysosomes to form autolysosomes in which autophagic substrates are broken 
down for reutilization (Mizushima, Levine et al. 2008; Mizushima 2011). The products of 
lysosomal degradation, or lysosomal catabolites, leave lysosomes through specific exporters on 
the perimeter membrane or through vesicular membrane trafficking (Sagne and Gasnier 2008; 
Ruivo, Anne et al. 2009) (Fig. 1.1).  Once they reach the cytoplasm or Golgi apparatus, these 
catabolites are either further degraded to provide energy or re-utilized by the anabolic and 
biosynthetic pathways to produce complex molecules.  Indeed, the synthesis of many complex 
lipids, such as the glycosphingolipids, mainly utilizes these lysosomal catabolites as their 
building blocks (Gillard, Clement et al. 1998).  Therefore, lysosomal function is important not 
only for catabolism, but also for cellular recycling and anabolism.  
3 
 
 Because the catabolic and anabolic pathways cross-talk with each other to regulate 
metabolic homeostasis, the endocytic and autophagic pathways that supply the catabolic cargo 
are highly regulated by cellular signaling and nutrient status (Settembre, Zoncu et al. 2012; 
Settembre, Fraldi et al. 2013).  For example, autophagy is triggered by starvation but terminated 
upon completion of lysosomal degradation (Yu, McPhee et al. 2010).  Indeed, lysosomes contain 
the amino acid and nutrient-sensing machinery that consists of V-ATPase, Rag GTPase, and 
mTOR (Settembre, Zoncu et al. 2012). Consistent with this, lysosomes have been shown to have 
a much broader role in cellular physiology than just degradation, including roles in secretion, 
plasma membrane repair, cellular metabolism, and signaling transduction (Luzio, Pryor et al. 
2007; Settembre, Fraldi et al.). Hence, lysosomes should not be viewed as a dead-end 
degradative compartment, but rather as highly dynamic organelles that integrate multiple 
metabolic pathways to maintain cellular homeostasis.   
 
1.2 Lysosomal storage disorders 
Lipids, such as sphingolipids, glycolipids, phospholipids, and cholesterol, are the 
essential structural constitutes of plasma membranes and the membranes of intracellular 
compartments (Schulze and Sandhoff 2011).  In addition, many of them, such as phospholipids, 
also serve as signaling molecules.  While lipid synthesis is initiated in the endoplasmic reticulum 
(ER), lipid degradation occurs in lysosomes, which are filled with various acid lipases (Schulze 
and Sandhoff 2011). Unlike water soluble substrates, such as proteins that are directly accessible 
to lysosomal proteases and peptidases, the digestion of membrane-bound complexes takes place 
in intraluminal vesicles, and requires both lipid-binding activator proteins and anionic lipids such 
as bis(monoacylglycero)phosphate (BMP)  (Kolter and Sandhoff 2010).  
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While lysosomal perimeter membrane is protected from degradation by the glycocalyx, it 
has been shown that intraluminal vesicles (the MVBs) are the main degradation sites for 
membrane lipids (Fig. 1.1) (Kolter and Sandhoff 2010). Within the MVBs, membrane stabilizing 
cholesterol is sorted and exported out via the cholesterol-binding NPC1 and NPC2 proteins 
(Cheruku, Xu et al. 2006; Infante, Wang et al. 2008). Auxiliary lipid binding proteins then 
solubilize and present the complex lipids to hydrolases for degradation (Schulze, Kolter et al. 
2009; Kolter and Sandhoff 2010). Complex lipids such as sphingoglycolipids require both 
lipases and carbohydrases for degradation (Kolter and Sandhoff 2010).  Because there are 
multiple steps involved in lipid degradation, impairment of any of these lipid or carbohydrate 
hydrolases would be expected to result in an accumulation of the various undigested lipids in the 
lysosome (Schulze and Sandhoff 2011).  
Accumulation of undigested lipids or other biomaterials in the lysosome leads to a group 
of metabolic disorders collectively called lysosomal storage diseases (LSDs) (Parkinson-
Lawrence, Shandala et al. 2010). LSDs are traditionally classified by the nature of undigested 
materials within the lysosomes; hence, lipidoses are the most common LSDs.  However, 
undigested lipids may also accumulate due to secondary mechanisms, for example, secondary to 
carbohydrate accumulation or membrane trafficking (Neufeld 1991).  Therefore, a more useful 
classification is based on the mutations specific for each LSD. Most LSDs are caused by 
mutations in lysosomal hydrolases (Schulze, Kolter et al. 2009; Schulze and Sandhoff 2011).  
However, defective membrane trafficking and catabolite export could cause a “traffic jam”, 
resulting in secondary lipid storage in the lysosome (Fig. 1.2) (Parkinson-Lawrence, Shandala et 
al. 2010).  Furthermore, primary accumulation of undigested, insoluble lipids may also cause a 
“traffic jam” to slow down membrane trafficking and sorting and ultimately affects the delivery 
5 
 
of lysosomal hydrolases to lysosomes and the inhibition of cargo degradation (Parkinson-
Lawrence, Shandala et al. 2010).  In addition, insoluble lipids may also precipitate in the 
lysosomes to reduce the activity of hydrolytic enzymes.  Subsequently, secondary storage of 
ubiquitinated proteins, carbohydrates, or other lipids may occur.  Hence, most LSDs manifest 
heterogeneity in storage lipids in the lysosome.   
Progressive accumulation of undigested lipids and protein aggregates, primarily or 
secondarily, leads to build-up of enlarged (> 500 nm) but dysfunctional lysosomes. These 
enlarged “lysosomes” are presumably endolysosomes and autolysosomes, which under normal 
conditions are used to regenerate new lysosomes, via the process of lysosome reformation, upon 
completion of lysosomal degradation (Yu, McPhee et al. 2010). Hence, LSD is a state of 
endocytic and autophagic “block” or “arrest” (Lieberman, Puertollano et al. 2012). Subsequently, 
although total number of lysosomes is not reduced in LSDs, the overall lysosomal function 
within a cell is compromised, and this can lead to severe cellular consequences. First, 
accumulation of undigested materials in the lysosome causes the depletion of the building blocks 
that are necessary for the biosynthesis of complex molecules and anabolism. Hence, LSDs must 
bear the consequence of cellular starvation (Schulze and Sandhoff 2011) (Fig. 1.2). Second, 
accumulation of various membrane-bound lipids may affect the properties and integrity of the 
perimeter membrane (Walkley 2009; Walkley and Vanier 2009).  Third, lipid storage may alter 
the functionality of lysosomal membrane proteins, such as V-ATPase, lysosomal ion channels, or 
catabolite exporters, eventually affecting the physiology and ionic composition of lysosomes.  
Altered heavy metal ion homeostasis may increase oxidative stress to cause lipid peroxidation, 
affecting membrane integrity (Dong, Cheng et al. 2008). 
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In an attempt to compensate for lysosomal dysfunction and reduced power in 
degradation, most LSD cells exhibit an increase in basal autophagy and expression levels of 
house-keeping lysosomal proteins such as Lamp-1 (Ballabio and Gieselmann 2009). These 
compensatory changes may allow LSD cells to survive under normal, non-stressed conditions.  
Under stressed conditions, however, altered luminal ion homeostasis and membrane integrity 
may cause lysosomal membrane permeabilization, leading to the leakage of lysosomal enzymes 
into the cytoplasm thereby triggering cell death (Boya and Kroemer 2008).  An increase in cell 
death would result in permanent damage to tissues and organs with large amounts of post-mitotic 
cells, including the brain, liver, eye, muscle, and spleen (Neufeld 1991).  Hence, the most 
common manifestations in LSDs are neurodegeneration, mental retardation, and motor 
disabilities (Parkinson-Lawrence, Shandala et al. 2010).  
Several therapeutic approaches have been developed for LSDs, such as substrate 
reduction, bone-marrow transplantation, gene therapy, and enzyme replacement therapy (ERT) 
(Cox and Cachon-Gonzalez 2012).  However, most of these approaches are limited to only one 
type of LSD, and often not very effective.  More importantly, for most LSDs, an effective 
therapeutic approach is still lacking.  To develop a common approach for most LSDs, it is 
necessary to understand how defective cellular pathways are interconnected to impact the 
cellular viability and physiology.  Several recent studies revealed that lysosomal exocytosis, one 
of the two most important lysosomal trafficking pathways in the outward direction (Fig. 1.1), is 
defective in multiple LSDs (LaPlante, Sun et al. 2006; Medina, Fraldi et al. 2011). Most 
intriguingly, induction of lysosomal exocytosis was found to facilitate the clearance of stored 
materials regardless of the nature and cause of the storage (Medina, Fraldi et al. 2011; Settembre, 
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Fraldi et al. 2013).  The importance of lysosomal exocytosis as a therapeutic target for LSDs is 
explored more in later chapters. 
 
2.  Dynamics of lysosomal exocytosis  
2.1 Regulated secretion of lysosomes and its biological importance  
Exocytosis of secretory lysosomes (lysosome-related organelles) has been long known to 
be present in specialized cell types such as hematopoietic cells (Stinchcombe and Griffiths 
1999).  However, the regulated exocytosis of conventional lysosomes was first observed in CHO 
and NRK fibroblasts, but is now known to be present in all cell types (Andrews 2000; 
Gerasimenko, Gerasimenko et al. 2001; Reddy, Caler et al. 2001).  Upon stimulation, lysosomes 
translocate from the perinuclear region to the plasma membrane along the microtubules 
(Rodriguez, Webster et al. 1997; Andrews 2000; Reddy, Caler et al. 2001; Jaiswal, Andrews et 
al. 2002). After docking, lysosomes fuse directly with the plasma membrane and release the 
lysosomal contents into the extracellular space.  Lysosomal exocytosis represents the major 
output pathway of the lysosome (Fig. 1.1) and is important for a variety of cellular processes. 
There are two primary purposes for lysosomal exocytosis depending on the tissue and cell type; 
membrane remodeling and secretion (Fig. 1.3). Lysosomal exocytosis induced membrane 
remodeling has been shown to contribute to neurite outgrowth in neurons (Arantes and Andrews 
2006), membrane repair in muscle cells (Reddy, Caler et al. 2001), particle ingestion during 
phagocytosis in macrophages (Braun, Fraisier et al. 2004; Czibener, Sherer et al. 2006), and 
cancer cell metastasis and motility (Kirkegaard and Jaattela 2009).  On the other hand, lysosomal 
exocytosis induced secretion contributes to antigen presentation by major histocompatibility 
complex  class II (MHC II) (Cresswell 1994), bone absorption in osteoclasts (Mostov and Werb 
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1997), axonal myelination in Schwann cells (Chen, Zhang et al. 2012), and lytic granule content 
secretion by cytotoxic T lymphocytes (Blott and Griffiths 2002) (Fig. 1.3). Collectively, all of 
these indicate the importance of lysosomal exocytosis in a variety of biological functions and the 
importance of understanding its molecular machinery.  
 
2.2 The molecular machinery and regulators of lysosomal exocytosis  
Compared with synaptic vesicle exocytosis, a process sharing many similarities with 
lysosomal exocytosis (Sudhof 2013), the molecular mechanisms underlying lysosomal 
exocytosis are much less understood (Rodriguez, Webster et al. 1997; Sudhof 2013).  Both 
processes involve several pre-fusion steps in tethering/docking and several post-docking steps in 
membrane fusion.  However, distinct sets of exocytosis machinery are employed, including 
SNAREs that bring the two membranes closer to each other.  More importantly, both fusion 
events are regulated by Ca
2+
 and the same family of Ca
2+
 sensors.   
 
2.2.1 Microtubule and motor proteins.   
Lysosomes undergo both short range actin-based and long-range microtubule-based 
movements (Luzio, Pryor et al. 2007; Huotari and Helenius 2011).  Under resting conditions, 
lysosomes are mostly localized in the perinuclear microtubule-organizing center (Settembre, 
Fraldi et al. 2013). Upon stimulation, there is an increase in both lysosome mobility and the 
number of lysosomes localized under the plasma membrane (lysosomal docking) (Spampanato, 
Feeney et al. 2013). It has been shown that lysosome mobility is increased when the 
microtubule-dependent motor kinesin and dynein motor proteins are up-regulated (Mrakovic, 
Kay et al. 2012). Likewise, lysosomal docking is also dependent on microtubules (Medina, 
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Fraldi et al. 2011). Therefore, it is possible that the conditions needed to increase lysosome 
mobility may also increase lysosomal docking and exocytosis.  It remains to be investigated 
whether lysosomal exocytosis is increased under these manipulations.   
 
2.2.2 SNARE proteins  
Similar to the exocytosis of synaptic vesicles as well as endosome-endosome fusion, the 
fusion of lysosomes with the plasma membrane is mediated by soluble N-ethylmaleimide-
sensitive factor-attachment protein receptor (SNARE) complexes (Jahn and Scheller 2006). 
SNARE proteins are characterized by the existence of a coiled-coil homology domain (Jahn and 
Scheller 2006; Jahn and Fasshauer 2012). During lysosomal exocytosis vesicle-associated 
membrane protein 7 (VAMP7) localizes on the surface of the lysosomes, forms a trans-SNARE 
complex with syntaxin-4 and synaptosome-associated protein of 23kDa (SNAP23) on the plasma 
membrane (Rao, Huynh et al. 2004) (Fig. 1.4). The formation of the trans-SNARE complex pulls 
the lysosome and plasma membrane toward each other and docks the lysosome on the 
cytoplasmic side of the plasma membrane (Fig. 1.4). Lysosomal exocytosis is blocked by the 
expression of dominant-negative VAMP7 constructs in macrophages (Braun, Fraisier et al. 
2004).   
 
2.2.3 The role of Ca
2+
 in lysosomal exocytosis  
After lysosomes are docked on the plasma membrane by the formation of the trans-
SNARE complex, the final step of fusion requires a localized rise in intracellular Ca
2+
 levels 
(Rodriguez, Webster et al. 1997; Andrews 2000; Reddy, Caler et al. 2001).  In response to a 
small increase in free Ca
2+
 levels in the cytoplasm, artificially induced by Ca
2+
 ionophores or 
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membrane disruptions, lysosomal exocytosis levels have been shown to increase (Chavez, Miller 
et al. 1996; Coorssen, Schmitt et al. 1996; Ninomiya, Kishimoto et al. 1996; Rodriguez, Webster 
et al. 1997; Rodriguez, Martinez et al. 1999).  The cytosolic [Ca
2+
] required for lysosomal 
exocytosis is predicted to be > 1 µM (Rodriguez, Webster et al. 1997), which is higher than the 
optimal 0.5 µM required for late endosome-lysosome fusion in cell-free vesicle mixing assays 
(Pryor, Mullock et al. 2000).  During synaptic exocytosis, a very rapid increase in cytosolic Ca
2+
 
is required to mediate the fast (< 1 ms) fusion of synaptic vesicles with the pre-synaptic 
membrane (Pang and Sudhof 2010).  This increase in Ca
2+
 occurs locally near the site of 
exocytosis and is mediated by the flux of Ca
2+
 via the voltage-gated Ca
2+
 channels on the pre-
synaptic membrane in response to depolarization (Xu, Mashimo et al. 2007).  In contrast, the 
source of Ca
2+
 and the identity of the Ca
2+
 channel(s) for lysosomal exocytosis have remained 
elusive.   
The Ca
2+
 required for the late endosome-lysosome and lysosome-plasma membrane 
fusion has been suggested to come from the lysosomal lumen (Fig. 1.4).  Like the ER, which is 
the main intracellular Ca
2+
 store with an estimated [Ca
2+
]lumen of 0.5-2 mM (Miyawaki, Llopis et 
al. 1997; Burdakov, Petersen et al. 2005), lysosomes are also Ca
2+
 stores with free [Ca
2+
]lumen of 
400-600 µM (Haller, Dietl et al. 1996; Haller, Volkl et al. 1996; Lloyd-Evans, Waller-Evans et 
al. 2010; Lloyd-Evans and Platt 2011).  In cell-free vesicle fusion assays, late endosome-
lysosome fusion is inhibited by the Ca
2+
 chelator BAPTA, but not EGTA (Luzio, Rous et al. 
2000; Luzio, Bright et al. 2007).  Although both BAPTA and EGTA have a high binding affinity 
for Ca
2+
, BAPTA binds to Ca
2+
 approximately 100 times faster than EGTA does.  Therefore, it is 
likely that the source of Ca
2+
 must be very close to the fusion spot.  In other words, lysosomes 
themselves most likely provide the Ca
2+
 required for lysosomal fusion (Pryor, Mullock et al. 
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2000; Luzio, Bright et al. 2007). Therefore, lysosomes may provide Ca
2+
 for membrane fusion 
between lysosomes and plasma membrane during lysosomal exocytosis (Fig. 1.4). Collectively, 
these data suggest that the Ca
2+
 required for lysosomal exocytosis can potentially be provided 
from the lumen of the lysosomes undergoing lysosomal exocytosis. This possibility is explored 
in Chapter II and the results will be discussed later.  
 
2.2.4 The lysosomal Ca
2+
 sensor Synaptotamin VII   
The Synaptotagmin (Syt) family of Ca
2+
 sensor proteins has 16 members, each containing 
two Ca
2+
-binding C2 domains on the cytosolic side (Chapman 2008). During synaptic vesicle 
fusion with the plasma membrane, the localized increase in cytoplasmic [Ca
2+
] activates Syt-I on 
the surface of the synaptic vesicles triggering the final step of fusion (Sudhof 2013).  Due to the 
following pieces of evidence, it is likely that SytVII is the Ca
2+
 sensor for lysosomal exocytosis 
(Fig. 1.4).  First, Syt-VII is ubiquitously expressed and localized on the lysosomes (Rodriguez, 
Webster et al. 1997; Rodriguez, Martinez et al. 1999; Andrews 2000; Reddy, Caler et al. 2001; 
Rao, Huynh et al. 2004; Arantes and Andrews 2006). Second, cells isolated from SytVII KO 
mice exhibit reduced ionomycin-induced lysosomal exocytosis (Coorssen, Schmitt et al. 1996; 
Rodriguez, Webster et al. 1997; Rodriguez, Martinez et al. 1999; Andrews 2000; Gerasimenko, 
Gerasimenko et al. 2001; Reddy, Caler et al. 2001; Rao, Huynh et al. 2004; Arantes and 
Andrews 2006; Czibener, Sherer et al. 2006). Lastly, dominant-negative SytVII also inhibits 
lysosomal exocytosis (Reddy, Caler et al. 2001; Czibener, Sherer et al. 2006). All together, these 
data indicate that SytVII is the Ca
2+
 sensor for lysosomal exocytosis. Likewise, lysosome-
mediated bacterial killing is defective in SytVII KO macrophages (Roy, Liston et al. 2004) 
suggesting that SytVII is also involved in phagosome-lysosome fusion. However, vacuole fusion 
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studies by cell free fusion assays have shown that 0.5µM Ca
2+
 is optimal for fusion of late 
endosomes with lysosomes (Pryor, Mullock et al. 2000), which is significantly less than the 1µM 
Ca
2+
 suggested to be required for the activation of SytVII and lysosomal exocytosis (Rodriguez, 
Webster et al. 1997). Therefore, the involvement of SytVII in late endosome-lysosome fusion 
events is not clear. But it should be noted that cell free experiments do not resemble the native 
intracellular environment and the experimental conditions used in these assays do not allow for 
the accurate measurement of Ca
2+ 
concentrations, therefore, these data should be considered with 
caution. Because lysosomal exocytosis is not completely abolished in the SytVII KO, other Syt 
proteins may also participate in lysosomal exocytosis.  In addition, other Ca
2+
 sensors may also 
be involved.  For example, calmodulin, which is implicated in late endosome-lysosome fusion 
(Pryor, Mullock et al. 2000), and ALG-2, a lysosome-targeted EF hand Ca
2+
 binding protein, 
may play roles in lysosomal exocytosis (Vergarajauregui, Martina et al. 2009).   
The mechanisms by which SytVII promote lysosomal exocytosis are not clear.  
Extrapolated from synaptic vesicle exocytosis (Chapman 2008; Sudhof 2013),  the Ca
2+
-bound 
C2 domain may increase phosphoinositide binding in order to bring the lysosomes within close 
proximity of the plasma membrane.  The resulting force may increase membrane curvature, 
facilitating lipid bilayer mixing (Chapman 2008). 
 
2.2.5 TFEB the transcription factor regulating lysosomal exocytosis  
bHLH-leucine zipper transcription factor EB (TFEB) is a master regulator of both 
lysosomal biogenesis and autophagy (Sardiello and Ballabio 2009; Sardiello, Palmieri et al. 
2009; Settembre, Di Malta et al. 2011; Settembre, Fraldi et al. 2013). When autophagy is 
triggered or when lysosomes are under stressed conditions, such as lysosomal storage, TFEB 
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proteins translocate from the cytoplasm to the nucleus, inducing the expression of its target 
genes.  Bioinformatics analysis suggested that TFEB regulates the expression of lysosomal 
related genes by binding to the coordinated lysosomal expression and regulation (CLEAR) motif 
(Sardiello and Ballabio 2009; Settembre, Di Malta et al. 2011). Indeed overexpression of TFEB 
in HeLa cells causes an increase in the expression of 291 genes, mostly involved in lysosomal 
biogenesis through the CLEAR network, supporting the hypothesis that lysosomal related genes 
are regulated under a similar master network (Sardiello and Ballabio 2009; Settembre, Di Malta 
et al. 2011).  
TFEB has been shown to regulate both docking and fusion of lysosomes with plasma 
membrane through the expression of a specific set of genes (Fig. 1.4) (Medina, Fraldi et al. 
2011). TFEB most likely regulates lysosomal fusion with the plasma membrane through the 
expression of TRPML1, the lysosomal Ca
2+
 channel on the surface of lysosomes, as TFEB 
overexpression has been shown to induce a TRPML1 mediated Ca
2+
 increase in the cytoplasm 
(Medina, Fraldi et al. 2011) (a detailed overview of TRPML1 function is discussed in the next 
section) . However, it is not clear how TFEB regulates lysosomal docking on the plasma 
membrane. TFEB can potentially increase the expression and activity of kinesin and dynein 
motor proteins along the microtubules responsible for the trafficking of lysosomes to the plasma 
membrane (Matteoni and Kreis 1987), therefore increasing the docking of sub-plasma membrane 
lysosomes.  
 
2.2.5 Neuraminidase 1 as the negative regulator of lysosomal exocytosis 
Neuraminidase 1 (Neu1) is a lysosomal enzyme responsible for the cleavage of the 
terminal sialic acid residues from a variety of substrates in the lysosomes such as glycoproteins 
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and glycolipids.(Bonten, van der Spoel et al. 1996). Mutations in this gene can lead to a type of 
LSD called sialidosis (Pshezhetsky, Richard et al. 1997). Interestingly, in addition to its 
degradation role inside lysosomes, Neu1 has been shown to negatively regulate lysosomal 
exocytosis by controlling lysosomal membrane integrity through the mediation of sialic acid in 
the lysosomal membrane protein Lamp-1 (Yogalingam, Bonten et al. 2008). Neu1 function has 
been shown to be essential for the docking of lysosomes on the plasma membrane as cells 
isolated from Neu1 KO mice exhibit a significant increase in docked lysosomes on the plasma 
membrane (Yogalingam, Bonten et al. 2008). Consequently, lysosomal exocytosis is up-
regulated in Neu1 KO cells leading to increased lysosomal secretion into the extracellular space 
and abnormal remodeling of the plasma membrane. 
 
3. TRPML1 as the principal lysosomal Ca
2+
 channel 
3.1 TRPML family of cation channels 
  Transient Receptor Potentials (TRPs) are a family of non-selective Ca
2+
 channels that 
were initially believed to operate solely at the plasma membrane. TRPs were primarily shown to 
be involved in regulating intracellular Ca
2+
 levels (Montell 2005). TRPs include six subfamilies 
that have been shown to be expressed in most tissues and cell types.  TRPML (TRP-Mucolipin) 
is one of the recently characterized subfamilies of the TRP channels. The TRPML subfamily 
includes three members, TRPML1, TRPML2, and TRPML3, with TRPML1 being the best 






3.2 TRPML channel structure 
Based on bioinformatic and biochemical studies, it is well accepted that all TRPML 
family members have six transmembrane domains (TM1-6) with the amino and carboxy termini 
facing the cytosol. In contrast to other TRP channels, TRPML channels contain a large loop 
expanding between TM1 and TM2 (Fig. 1.5) (Puertollano and Kiselyov 2009; Cheng, Shen et al. 
2010). TRPML family proteins share high amino acid sequence similarity (about 75%), with the 
highest similarity being in the pore region between TM5 and TM6 (more than 90% sequence 
similarity) (Puertollano and Kiselyov 2009; Cheng, Shen et al. 2010). The large loop between 
TM1 and TM2 contains several N-glycosylation sites. This loop has been reported to get cleaved 
between the second and third glycosylation sites late in the biosynthetic pathway, which could 
potentially regulate TRPMLs localization and/or functions (Miedel, Weixel et al. 2006).  
 
3.3 Subcellular localization and tissue expression pattern of TRPMLs 
Studies using overexpressed TRPML proteins fused with various reporter genes have 
revealed that TRPMLs primarily localize to a population of membrane-bound vesicles along the 
endosomal/lysosomal pathways in a variety of host cells. GFP-fused TRPML (TRPML1-GFP) is 
mainly colocalized with Lamp-1, a late endosome and lysosome marker (Dong, Cheng et al. 
2008). Thus, TRPML1 is considered to be a TRP channel specifically localized on the lysosomes 
(Cheng, Shen et al. 2010). Using a similar approach, TRPML2 and TRPML3 were also found in 
Lamp-1 labeled compartments. However, they were shown to have more diverse localization. 
TRPML3 was shown to be localized in compartments that are positive for Rab5, an early 
endosome-specific small GTPase  (Kim, Li et al. 2007; Cuajungco and Samie 2008; Kim, 
Soyombo et al. 2009). TRPML2 is also present in Arf6-positive recycling endosomes 
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(Karacsonyi, Miguel et al. 2007). In addition to overexpression studies, the cellular localization 
of TRPML1 and TRPML3 has also been investigated using cellular fractionation (Kim, 
Soyombo et al. 2009). These studies confirmed that TRPML1 mainly localizes with Lamp-1, 
while TRPML3 was shown to localize with both markers of early and late endosomes 
(Karacsonyi, Miguel et al. 2007). The lysosomal localization of the TRPML1 is mediated by two 
individual di-leucine motifs existing near the N- and C- terminals of the protein. The acidic di-
leucine motif at the N-terminal (E11TERLL) regulates the direct localization of the newly 
synthesized protein from the Golgi to the late endosomes-lysosomes. The di-leucine motif at the 
C- terminal tail (E573EHSLL) arbitrates an indirect localization of TRPML1 from the Golgi to 
the cell membrane where it is internalized and delivered to the late endosomal-lysosomal 
pathways. Mutations in both di-leucine motifs block the transport of TRPML1 from Golgi to late 
endosome-lysosomes (LELs) and trap the channel on the plasma membrane (Vergarajauregui 
and Puertollano 2006).   
The tissue distribution of TRPMLs has mainly been investigated by measuring mRNA 
expression levels using nucleotide-based techniques such as real-time polymerase chain reaction 
(RT-PCR), northern blot, and in situ hybridization. By using such techniques, TRPML1 was 
shown to be expressed in most of the tissues across the body with the highest levels of 
expression in the brain, kidney, spleen, liver, and heart (Falardeau, Kennedy et al. 2002).  In 
contrast to TRPML1, the expression of TRPML2 and TRPML3 was shown to be more restricted. 
Mouse TRPML2 mRNA was shown to be expressed mainly in lymphoid organs, such as thymus 
and spleen, suggesting an important and very selective physiological role for TRPML2 in the 
immune system (Samie, Grimm et al. 2009). TRPML3 mRNA was shown to be detectable in the 
thymus, lung, kidney, spleen, and eye (Samie, Grimm et al. 2009). In addition, in situ 
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hybridization revealed the expression of TRPML3 in epithelial cells of the inner ear, including 
strial and hair cells (Di Palma, Belyantseva et al. 2002).  
 
3.4 The permeation properties of TRPML channels 
The biophysical properties, including channel permeation, of TRPML channels were 
extremely difficult to study due to their localization on the lysosomal compartments. However, 
the development of a new patch-clamp technique allowed for direct patching of the lysosomes 
(whole-lysosomal recording) (Dong, Cheng et al. 2008; Dong, Shen et al. 2010), which allowed 
for the direct study of TRPMLs in their native environment. By using the whole-lysosome 
recording technique, it was shown that TRPML exhibits an inward rectifying current indicating 
the movement of cations out of the lysosomal lumen and into the cytoplasm (Fig. 1.5). TRPMLs 
exhibit high permeability to Ca
2+
, serving as a potential lysosomal Ca
2+
 channel. In addition, 
TRPMLs are also permeable to divalent heavy trace metals such as iron and zinc (Dong, Cheng 
et al. 2008) which may have important implications in lysosomal functions. 
 
3.5 The activation mechanism of TRPML proteins 
Phosphoinositides have been shown to regulate the activation of TRPMLs depending on 
the cellular localization of the channel. The late endosome/lysosome specific phosphoinositide, 
PI(3,5)P2, has been shown to strongly activate all three TRPML channels on the surface of 
lysosomes (Dong, Shen et al. 2010). PI(3,5)P2 most likely activates TRPMLs by directly binding 
to a cluster of positively charged amino acid residues on the N-terminus of the channel which 
faces the cytoplasm (Fig. 1.5) (Dong, Shen et al. 2010). In contrast to the role of PI(3,5)P2 as the 
endogenous activator for TRPMLs, the plasma membrane-specific phosphoinositide, PI(4,5)P2, 
has been shown to inhibit the function of TRPML1 on the surface of cells (Zhang, Li et al. 
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2012). Interestingly, PI(4,5)P2 mediated inhibition also depends on the positively charged amino 
acid residues on the N-terminus suggesting that the N-terminus of TRPML1 is involved in the 
compartment specific regulation of TRPML1 channel activity. 
 
3.6 The channel function of TRPML1 proteins 
Considering the permeability characteristics of TRPMLs, it has been suggested that the 









lysosome lumen into the cytoplasm  in response to various cellular cues (Cheng, Jin et al. 2010). 
Lysosomal Ca
2+
 release has been shown to be important for various biological functions such as 
signal transduction, organelle homeostasis, and lysosomal acidification (Luzio, Bright et al. 
2007; Luzio, Pryor et al. 2007). As mentioned before, TRPML1 is the best characterized protein 
among the TRPML family and its role in lysosomal Ca
2+
 release has been heavily studied 
(Cheng, Jin et al. 2010). Collectively, all of these data established the importance of TRPML1 as 
the main lysosomal channel responsible for lysosomal Ca
2+ 
release (Cheng, Jin et al. 2010).  




, suggesting that they may also participate 
in the regulation of cellular homeostasis for these heavy metals (Dong, Cheng et al. 2008). In 
correlation with this, cells lacking TRPML1 exhibit an overload of lysosomal Fe
2+
 (Dong, Cheng 
et al. 2008) and Zn
2+
 (Eichelsdoerfer, Evans et al. 2010), suggesting that TRPML1 contributes to 
the transport of cations out of the lysosomes.  
 
3.7 The physiological importance of TRPML1  
TRPML1 was first identified by positional cloning approach aiming to characterize the 
gene underlying the human Mucolipidosis type IV disease (Bassi, Manzoni et al. 2000; Bargal, 
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Avidan et al. 2001). Mucolipidosis type IV (MLIV) is a neurodegenerative LSD characterized by 
mental and psychomotor retardation, hypotonia, iron deficiency anemia, achlorhydria, retinal 
degeneration, and visual problems including corneal clouding and retinal degeneration (Amir, 
Zlotogora et al. 1987; Altarescu, Sun et al. 2002; Puertollano and Kiselyov 2009). On the cellular 
level, similar to other LSDs, MLIV is characterized by the formation of large vacuoles along the 
endo-lysosomal pathway. Consistent with the ubiquitous expression pattern of TRPML1 in most 
tissues, the enlarged vacuole phenotype is observed in all cell types of MLIV patients and 
TRPML1 knockout mice (Bargal, Avidan et al. 2000; Bassi, Manzoni et al. 2000; Bargal, Avidan 
et al. 2001). 
Electron microscopy and HPLC analysis have illustrated that the enlarged vacuoles 
observed in TRPML1 deficient cells are filled with an abnormal amount of undigested lipids 
such as sphingolipids, phospholipids, and cholesterol (Micsenyi, Dobrenis et al. 2009). Based on 
these observations it was originally suggested that TRPML1 could potentially regulate lysosomal 
pH and therefore affect the function of lysosomal hydrolases involved in lipid metabolism. This 
hypothesis was supported by studies showing that lysosomes in TRPML1 deficient cells are over 
acidified (Soyombo, Tjon-Kon-Sang et al. 2006; Miedel, Rbaibi et al. 2008). However, later it 
was revealed by biochemical studies that the hydrolase activities of lysosomal enzymes are 
normal in TRPML1 deficient cells (Puertollano and Kiselyov 2009). Studies done in the past 
several years have suggested that TRPML1 is involved in membrane fusion process by acting as 
a lysosomal Ca
2+
 release channel, thereby regulating membrane trafficking along the endo-
lysosomal pathway by providing the Ca
2+
 necessary for the final step of fusion (Cheng, Shen et 
al. 2010; Dong, Shen et al. 2010). Considering this, it was suggested that the accumulation of 
lipids in the lysosomes of MLIV patients is possibly due to defective lysosomal trafficking 
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pathways as a result of a lack of lysosomal Ca
2+
 release and defective fusion machinery (Miedel, 
Rbaibi et al. 2008). 
In correlation with this idea, cells lacking TRPML1 have been shown to be defective in 
several lysosomal membrane trafficking pathways (Fig. 1.6). The knockdown of TRPML1 in  
macrophage cell lines and fibroblasts isolated from MLIV patients demonstrated a delay in the 
lysosomal delivery and subsequent degradation of endocytosed proteins, such as BSA and 
platelet-derived growth factor receptors (PDGF-R) (Thompson, Schaheen et al. 2007; 
Vergarajauregui, Oberdick et al. 2008) (Fig. 1.6). However, such a delay was not observed in 
HeLa cells with transient knockdown of TRPML1 (Miedel, Rbaibi et al. 2008), suggesting that 
the regulatory role of TRPML1 along the endosomal pathway is potentially cell type-specific.  
Additionally, fibroblasts and neurons obtained from MLIV patients and TRPML1 KO 
mice showed an increase in autophagosome formation and delayed autophagosome degradation, 
which suggests that TRPML1 is possibly involved in the fusion of autophagosomes with 
lysosomes during autophagy (Fig. 1.6) (Vergarajauregui, Connelly et al. 2008). Consequently, 
autophagosomes undergo inefficient digestion and accumulate in TRPML-deficient cells. 
Interestingly, loss of TRPML1 function significantly enhances constitutive autophagy but not 
starvation-induced autophagy (Curcio-Morelli, Charles et al. 2010). 
Several lines of evidence suggest that TRPML1 plays a role in mediating lysosomal 
exocytosis. First, overexpression of TRPML1Va (a gain-of-function mutation) results in the 
appearance of Lamp-1 lysosomal protein on the plasma membrane indicating an increase in 
lysosomal exocytosis (Dong, Wang et al. 2009). Second, TFEB induced lysosomal exocytosis 
has been shown to be dependent on the Ca
2+
 released through TRPML1 (Medina, Fraldi et al. 
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2011). Third, ML-IV patients exhibit impaired ionomycin-induced lysosomal exocytosis 
(LaPlante, Sun et al. 2006). Lastly, the shRNA knockdown of TRPML1 in macrophage cell lines 
delayed the transport of the major Histocompatibility Complex II (MHCII) from LEL 
compartments in response to immune stimulation, a process that has been shown to be dependent 
on lysosomal exocytosis (Thompson, Schaheen et al. 2007). Collectively, these data suggest that 
TRPML1 is possibly involved in regulating lysosomal exocytosis. 
Even though several studies illustrated the importance of TRPML1 in membrane 
trafficking, the direct involvement of TRPML1 in these processes is not clear. Almost all these 
studies have been performed using genetic manipulations such as the use of TRPML1 KO cells. 
However, genetic defects could potentially lead to secondary chronic lysosomal disorders or 
other primary defects associated with TRPML1 (Miedel, Rbaibi et al. 2008). One way to 
separate the primary and secondary effects and to investigate the direct effect of TRPML1 in 
membrane trafficking is to evaluate such processes after acutely activating/inhibiting TRPML1 
in different cells. Indeed, the activation of TRPML1 by its newly developed specific activator 
was sufficient to induce and rescue the retrograde trafficking defects seen in Niemann–Pick type 
C (NPC) disease (Shen, Wang et al. 2012) indicating the importance and the direct effect 
TRPML1 has on membrane trafficking. In Chapter II I will explore the direct role of TRPML1 in 
lysosomal exocytosis by using its specific activator. Additionally, in order to further evaluate the 
role of TRPML1 in membrane trafficking, we have developed a TRPML1 specific inhibitor 





4. The dynamics of macrophages in different immunological functions  
4.1 Macrophage function in health and disease 
Almost all eukaryotic cells are able to internalize a variety of particles during their 
lifetime. Most cells are able to internalize small particles through receptor mediated endocytosis 
(Huotari and Helenius 2011; McMahon and Boucrot 2011). However, during evolution 
phagocytes, such as macrophages, have gained the ability to uptake large extracellular particles 
(1-10µm in diameter) through a very specialized process called phagocytosis (Aderem and 
Underhill 1999). Macrophages are produced during the differentiation of bone marrow derived 
monocytes and are found in most of the tissues across the body (Aderem and Underhill 1999).  
Macrophages are large (30-50 µm in diameter) and irregularly shaped cells. However, 
their shape is largely mediated by their location and degree of activation (Chawla 2010). The 
surface of macrophages is ruffled, which allows them to form large membrane extensions during 
phagocytosis (Huynh, Kay et al. 2007). Macrophages are one of the most plastic cell types in the 
body and they are able to change their function depending on the tissue they reside in (Chawla 
2010). In general, macrophages participate in two main biological functions; they actively 
participate in pathogen elimination in addition to being involved in tissue remodeling and 
apoptotic cell elimination (Aderem and Underhill 1999).  
Macrophages participate in maintaining tissue homeostasis, development, and cellular 
turnover by eliminating apoptotic or damaged cells (Wynn, Chawla et al. 2013). This function of 
macrophages is usually mediated by resident macrophages of each tissue such as liver, brain, 
bone, and spleen. Depending on the tissue, defects or any alteration in macrophage mediated 
cellular turnover or particle elimination can lead to severe consequences such as autoimmune 
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disease, neurodegeneration, osteoporosis, obesity, and iron deficient anemia (Chawla 2010; 
Wynn, Chawla et al. 2013). On the other hand, macrophages also play a crucial role in immune 
responses by eliminating the invading pathogen. Macrophages circulating in the blood are 
recruited to the infection site upon pathogen invasion where they serve as the first line of defense 
against pathogen infection. They ingest and eliminate the foreign pathogen which leads to 
subsequent activation of adaptive immune responses. Defects in pathogen elimination will lead 
to a high susceptibility to infectious agents such as tuberculosis and salmonella (Murray and 
Wynn 2011).  
 
4.2. Receptor mediated Phagocytosis 
 
Macrophages participate in tissue remodeling and pathogen clearance by engulfing 
extracellular particles through a highly regulated process called phagocytosis (Flannagan, 
Jaumouille et al. 2012). Phagocytosis is a receptor mediated event and can be divided into two 
separate sections. First, particle uptake/ingestion is initiated by particle binding to specific 
phagocytic receptors on the surface of the macrophages. Receptor activation triggers a cascade of 
signaling events to rapidly extend the plasma membrane around the particle(s). Plasma 
membrane extensions, called plasmalemmal pseudopods, form the phagocytic cups that ingest 
particles into vacuole-like structures, called phagosomes, within several minutes after particle 
binding (Niedergang and Chavrier 2004). The second phase is the phagosome maturation phase. 
After phagosome formation, the newly formed phagosome content resembles the extracellular 
space, which is not suitable for particle degradation. Therefore, the newly formed phagosomes 
undergo a series of membrane fusion and fission events that closely resembles the endocytosis 
pathway. These events are collectively referred to as phagosomal maturation (Vieira, Botelho et 
al. 2002). Once the phagosome formation is complete, the nascent phagosomes will fuse with the 
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early endosomal compartments and acquire early endosomal proteins such as EEA1 and RAB5-
GTPase. The association of phagosomes with early endosomes is transient and they will 
eventually fuse with lysosomes to create a new hybrid organelle called phagolysosomes. 
Phagolysosomes acquire lysosomal properties, such as lysosomal proteins (Lamp-1 and RAB7-
GTPase), hydrolase enzymes, and acidic pH, which allow particle degradation (Vieira, Botelho 
et al. 2002) (Fig. 1.7). Depending on particle size and the nature of the particle, phagosome 
maturation can take up to 30-45 minutes. 
 
4.3. Membrane requirement for phagosome formation during phagocytosis  
  As mentioned in the previous section, phagocytosis is initiated by the binding of 
macrophage surface receptors to ligands on the surface of the particles (Aderem and Underhill 
1999). Particles with different nature and origins can be taken up by macrophages; therefore it is 
not surprising that macrophages express a variety of phagocytosis specific receptors on their 
surface. But no matter what kind of particle is being ingested or what kind of receptor is being 
activated, particle binding induces the formation of pseudopod extensions around the particle 
(Aderem and Underhill 1999; Flannagan, Jaumouille et al. 2012), that leads to the internalization 
and the formation of phagosomes (Niedergang and Chavrier 2004). An extensive amount of 
plasma membrane is used during pseudopod extension. Therefore, a large amount of plasma 
membrane is internalized during receptor mediated phagtocytosis, especially when multiple 
and/or large particles are ingested (Braun and Niedergang 2006; Huynh, Kay et al. 2007). So, it 
is reasonable to assume that the overall cell surface area decreases during the ingestion of large 
or multiple particles. Although, a large amount of plasma membrane is internalized during 
phagocytosis, paradoxically, the overall surface area of the phagocytosing cells does not 
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decrease, and indeed increases significantly before the closing of the phagocytic cups 
(Holevinsky and Nelson 1998; Huynh, Kay et al. 2007). 
How do macrophages compensate for the loss of plasma membrane during phagosome 
formation? It was originally suggested that because the macrophage’s surface is ruffled, during 
particle ingestion the macrophage surface could potentially get stretched and the opening of the 
ruffled regions could compensate for the portion of plasma membrane used during phagosome 
formation. However, biological membranes lose their structural stability after they get stretched 
by about 4% of their original size (Hamill and Martinac 2001). Nonetheless, macrophages 
overall surface area was shown to increase by about 20% of its original size during the uptake of 
large particles (Hackam, Rotstein et al. 1998; Holevinsky and Nelson 1998). So the small 
amount of stretch available in plasma membrane is certainly not enough to compensate for the 
uptake of large particles. Interestingly, the increase in cell surface area was prevented by 
inhibitors of phosphatidylinositol 3-kinase, an enzyme critical for intracellular membrane 
trafficking, suggesting the involvement of intracellular membrane in pseudopod formation and 
cell expansion during phagocytosis (Cox, Tseng et al. 1999). 
 
4.4 The role of Endo-lysosomal membrane in phagosome formation 
In the past decade a new hypothesis has emerged suggesting that a pool of intracellular 
membranes fuse with the plasma membrane and provides the excess membrane necessary for 
pseudopod extension during particle uptake in phagocytosis (Braun, Fraisier et al. 2004; Braun 
and Niedergang 2006; Czibener, Sherer et al. 2006; Huynh, Kay et al. 2007) (Fig. 1.8).  In 
agreement with this hypothesis, disruption of the membrane fusion machinery, such as the 
disruption of SNARE complexes, resulted in defective phagocytosis (Allen, Yang et al. 2002; 
Braun, Fraisier et al. 2004; Vinet, Fukuda et al. 2008).  
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Several different cellular compartments have been suggested to be the source of the 
excess membrane during phagocytosis; however, recent studies have demonstrated that 
endosomal/lysosomal compartments are one of the main sources to provide the excess membrane 
required for pseudopod formation (Fig. 1.8). Most evidence to support this notion is based on the 
appearance of organelle-specific markers at the site of particle uptake before or at the time of 
phagosome formation. By performing such experiments, it was first established that fusion of 
recycling endosomes with plasma membrane is necessary for phagosome formation. Several 
recycling endosome specific proteins, such as VAMP3 (Allen, Yang et al. 2002), ARF6 
(D'Souza-Schorey, Li et al. 1995), Rab11 (Cox, Lee et al. 2000), and SytV (Vinet, Fukuda et al. 
2008), have been identified to be involved in this process, where the absence of any of these 
proteins leads to defective phagosome formation and particle uptake.  
In recent years several studies have demonstrated that, in addition to recycling 
endosomes, lysosomal fusion with the plasma membrane (lysosomal exocytosis) plays a role in 
phagosome formation (Fig. 1.8) (Braun, Fraisier et al. 2004; Czibener, Sherer et al. 2006; 
Huynh, Kay et al. 2007). Under such conditions, lysosomes are involved in the early steps of 
phagosome biogenesis/formation prior to the closing of the phagocytic cups. Fusion of 
lysosomes with the plasma membrane and the delivery of lysosomal membranes/proteins to the 
surface of the newly formed phagosomes are observed at the site of particle ingestion. 
Manipulations blocking lysosomal exocytosis significantly reduce particle uptake in 
macrophages (Braun, Fraisier et al. 2004; Czibener, Sherer et al. 2006; Huynh, Kay et al. 2007). 
VAMP7 is a specific late endosome/lysosome SNARE protein that was shown to be present at 
the site of particle uptake during particle ingestion. Also, cells deficient in VAMP7 have been 
shown to be defective in lysosomal exocytosis, pseudopod extension, and consequently particle 
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uptake (Braun, Fraisier et al. 2004). Recent studies have revealed that the lysosomal specific 
Ca
2+
 sensor SytVII regulates the fusion of VAMP7 containing vesicles with the plasma 
membrane. Macrophages isolated from SytVII KO mice have been shown to be defective in 
particle uptake. Interestingly, the defective uptake phenotype seen in SytVII KO macrophages is 
more severe and more apparent when macrophages are exposed to large number of particles or 
large sized particles (Czibener, Sherer et al. 2006), which is consistent with the requirement of 
lysosomal membrane delivery to the site of particle uptake when large particles are being 
ingested.  
Although it is not clear what distinguishes between the recruitment of recycling 
endosomes and lysosomes to the site of uptake, present data collectively suggest that the fusion 
of lysosomes with the plasma membrane is on demand and happens when macrophages are 
exposed to large particle (> 3 µm) or numerous amount of particles at once. In contrast, recycling 
endosomes fuse with the plasma membrane only when small particles are being ingested (Huynh, 
Kay et al. 2007). This difference between lysosome and recycling endosome may be related to 
the amount of plasma membrane that is required to enclose the particle and form the phagosome 
(Fig. 1.8).  
 
5. Phosphoinositides in cell regulation and membrane dynamics 
Phosphatidylinositols (PtdIns) are a group of membrane phospholipids existing on the 
cytosolic side of cellular compartments. PtdIns are synthesized mainly in the endoplasmic 
reticulum (ER) and then delivered to other cellular compartments. Once the PtdIns are delivered 
to their final cellular compartments they get reversibly phosphorylated on their inositol ring at 
the positions 3, 4, and 5, resulting in the generation of seven phosphoinositides (PI) molecules 
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(P13P, PI4P, PI5P, PI(3,4)P2, PI(3,5)P2, P1(4,5)P2, and PI(3,4,5)P3) (Di Paolo and De Camilli 
2006). PIs are low-abundance membrane lipids, each having a unique subcellular localization 
largely localized on the compartments within the endo-lysosomal pathway. PI4P and PI(4,5)P2 
are the most abundant PIs. They are primarily localized on the plasma membrane and participate 
in a variety of plasma membrane specific functions. In addition to the plasma membrane, PI4P is 
also localized on the Golgi membrane (Falkenburger, Jensen et al. 2010). PI3P is found on the 
cytoplasmic side of early and late endosomes and newly formed phagosomes and 
autophagosomes (Poccia and Larijani 2009). PI(3,5)P2 is produced on late endosomes and 
lysosomes using PI3P as the substrate (Zhang, Zolov et al. 2007; Zolov, Bridges et al. 2012). 
PI(3,4)P2 and PI(3,4,5)P3 are generated transiently upon activation of plasma membrane 
receptors (Falkenburger, Jensen et al. 2010). 
PIs can regulate membrane trafficking through at least two mechanisms. First, they 
recruit a variety of cytoplasmic effector proteins to specific organelles that facilitate membrane 
trafficking (Falkenburger, Jensen et al. 2010). These proteins must be recruited to each organelle 
at a very precise time in order to mediate membrane trafficking events. Rapid production and 
elimination of specific phosphoinositides by their regulatory enzymes provides an effective 
mechanism for this purpose. For example, PI3P on the surface of the early endosomes have been 
shown to be responsible for the recruitment of EEA1 to the surface of the early endosomal 
compartments (Zhang, Zolov et al. 2007; Zolov, Bridges et al. 2012). EEA1 is a tethering 
molecule that couples vesicle docking with SNAREs in order to facilitate the transition from 
early to late endosomes (Mills, Jones et al. 1999).  Second, PIs can directly bind and regulate the 
activity of different membrane proteins, such as ion channels, on the surface of the organelles 
potentially inducing membrane trafficking (Falkenburger, Jensen et al. 2010) For example, many 
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plasma membrane ion channels have been shown to be activated by PI(4,5)P2 (Di Paolo and De 
Camilli 2006). In addition, as mentioned before, the lysosomal Ca
2+
 channel TRPML1 has been 
shown to be activated by PI(3,5)P2 on the surface of the lysosomes and inactivated by PI(4,5)P2 
on the plasma membrane (Zhang, Li et al. 2012). Therefore, PIs have the ability to regulate 
organelle specific membrane trafficking events by recruiting trafficking specific proteins at the 
right time or directly activate molecules involved in trafficking.  
 
6. The central goal of this study  
New emerging data suggest that TRPML1 induced lysosomal Ca
2+
 release is involved in 
regulating lysosomal membrane trafficking events in various cell types, however, direct evidence 
to support this notion is still lacking. The overall goal of this work is to investigate the 
involvement of TRPML1 and lysosomal Ca
2+
 release in lysosomal membrane trafficking in 
macrophages. Here I first sought to investigate the direct involvement of TRPML1 in lysosomal 
exocytosis after acutely activating TRPML1 by its specific activator (Chapter II). Then, I 
investigating the role of TRPML1 in particle ingestion in macrophages, which is known to be 
dependent on Ca
2+
 dependent lysosomal exocytosis, by using mouse knockouts and synthetic 
agonists/antagonists of TRPML1 (Chapter III). Furthermore, I examined the activation 
mechanism of TRPML1 during lysosomal exocytosis and particle uptake (Chapter IV). In 
addition to the role of TRPML1 in lysosomal exocytosis, I also inspected the role of TRPML1 in 








Figure 1.1 Major trafficking routes in and out of the lysosomes.  
 
Lysosomes receive inputs from both endocytic and autophagic pathways. Endocytosed cargo 
including membranes, complex lipids, membrane proteins, and polysaccharides enter the 
endocytic pathway first to early endosomes and then intraluminal vesicle-containing late 
endosomes (MVBs). Late endosomes then fuse with lysosomes to form endolysosome hybrids. 
Damaged intracellular organelles enter the autophagic pathway in autophagosomes, which then 
fuse with lysosomes to form autolysosomes. Endocytosed and autophagocytosed cargo are 
degraded in endolysosomes and autolysosomes through lysosomal hydrolases. The resulting 
products are building-block precursor molecules for complex macromolecules. These catabolites 
are transported out of the lysosomes via specific exporters. Insoluble catabolites, such as lipids, 
can be transported to the Golgi apparatus for reutilization via the retrograde trafficking pathway. 
Alternatively, degradation products can also be released into the extracellular medium via 
lysosomal exocytosis. Lysosomal ion homeostasis and membrane trafficking are regulated by 





































Figure 1.2 Mechanisms leading to lysosomal storage disorders and their cellular 
consequences.  
 
Lysosome Storage Diseases (LSDs) are characterized by the progressive build-up of undigested 
materials, such as lipids or carbohydrates, within the lysosomes. Mutations in lipases, lipid 
phosphatases, and carbohydrases lead to the accumulation of undigested lipids and carbohydrates 
in the lysosome. Likewise, mutations in the catabolite exporters also lead to the accumulation of 
lipids and carbohydrates in the lysosome. Mutations in lysosomal accessory proteins lead to 
lysosomal trafficking defects. Mutations in lysosomal ion channels and transporters lead to 
defective ion homeostasis, which in turn affects membrane trafficking to cause lipid 
accumulation. Lipid storage causes “traffic jam” and secondary accumulation, resulting in 
lysosomal dysfunction, membrane permeabilization, and cellular starvation. Lysosomal 
membrane permeabilization may cause leakage of lysosomal enzymes into the cytoplasm to 






Figure 1.3 Processes known to be regulated by lysosomal exocytosis. 
Lysosomal exocytosis has been shown to mediate several different biological functions in 
different cell types. Lysosomal exocytosis has been shown to be implicated in cell motility and 
expansion in cancer cells. In immunological cells, lysosomal exocytosis has been shown to be 
critical for several processes such as content secretion, antigen presentation and large particle 
ingestion through phagocytosis. Also, lysosomal exocytosis has been shown to be crucial for 







Figure 1.4 The core molecular machinery involved in lysosomal exocytosis.  
Upon stimulation, VAMP7 on the surface of lysosomes interact with Syntaxin 4 and SNAP23 on 
the inner side of the plasma membrane to form the trans-SNARE complex. The formation of the 
trans-SNARE complex pulls lysosomes close to the plasma membrane and docks lysosomes on 
the inner side of the plasma membrane. The activity of Ca
2+
 sensor SytVII is required to initiate 
the final fusion step. The production of PI(3,5)P2 on the fusing lysosomes induces the activation 
of the lysosomal Ca
2+
 channel TRPML1 and the release of lysosomal Ca
2+
 into the close vicinity 
of the fusion site. Ca
2+
 release mediates the activation of SytVII and the induction of lysosomal 
fusion with the plasma membrane. The transcription factor TFEB has been shown to regulate 
lysosomal exocytosis by mediating the docking and fusion steps through regulation of the 













Figure 1.5 Schematic diagram of TRPML protein structure and molecular orientation. 
 
(A) The putative membrane topology of TRPML1 proteins. TRPML1 is made of six 
transmembrane (TM) domains. There is large extra cellular loop between TM1 and TM2 and the 
predicted pore region between TM5 and TM6. (B)  The proposed localization of TRPML at the 
plasma membrane and the membrane of lysosomes. Both N and C terminals face the intracellular 
region when the channel is located either at the cell membrane or at the lysosomes. TRPML 
activation leads to the release of cations, such as Ca
2+
















Figure 1.6 Lysosomal trafficking defects observed in TRPML1 KO cells 
 
Cells lacking TRPML1 have been shown to be defective in several different lysosomal 
membrane trafficking pathways. The delivery of ingested materials through receptor mediated 
endocytosis has shown to be defective in TRPML1 KO cells late in the lysosomal pathway. 
Additionally, autophagosome fusion with lysosomes and subsequent degradation of autophagic 
materials has been shown to be defective in cells isolated from MLIV patients, leading to the 
accumulation of cellular waste in the cells. Also, Ca
2+
 dependent lysosomal exocytosis shown to 
be inhibited in TRPML1 KD immune cells resulted in decreased lysosomal dependent antigen 























Figure 1.7 Schematic diagram of Receptor mediated phagocytosis  
Diagram illustrating some of the known molecular events that dictate phagosomal maturation 
process. After the formation of the nascent phagosome they first acquire Rab5, which recruits 
VPS34 (not shown) to generate PI3P on the surface of the phagosomes. Subsequently, 
phagosomes acquire late endosome/lysosomal markers such as Rab7, Lamp-1, and TRPML1. 
The pH of the phagosomal lumen is gradually decreased which allows for the degradation of 
ingested particle. On the surface of the lysosomes the kinase PIKfyve (not shown) is recruited, 







Figure 1.8 Sources of membrane delivered to the phagocytic cup 
During particle uptake recycling endosomes are recruited to the site of small particle ingestion 
and they have been shown to be the primary source of membrane for the enlargement of the 
phagocytic cup and pseudopods formation. The translocation of recycling endosomes has shown 
to be regulated by several proteins such as VAMP3, Rab11, and ARF6. In contrast to the uptake 
of small particles, lysosomes have been shown to be drafted to the site of large particle uptake 
through lysosomal exocytosis. Lysosomes fuse with the plasma membrane and as a result 
lysosomal membrane and membrane integral proteins get translocated to the phagocytic cup. 


















TRPML1 ACTIVATION IS REQUIRED FOR LYSOSOMAL 




Fusion of lysosomes with the plasma membrane, i.e, lysosomal exocytosis, has been 
shown to play a critical role in several physiological processes such as plasma membrane repair, 
particle uptake, and cytokine secretion. Lysosomal exocytosis is known to be induced by the rise 
of intracellular Ca
2+
 concentrations, but the source of Ca
2+
 and the underlying Ca
2+ 
channel(s) 
involved in this process remain elusive. Mucolipin TRP channel 1 (TRPML1) is a member of the 
TRP ion channel super-family known to be localized on the surface of the lysosomes. Here I 
found that the activation of TRPML1 by a potent TRPML1-specific membrane-permeable small-
molecule agonist is sufficient to induce lysosomal Ca
2+
 release and thus lysosomal exocytosis in 
wild type cells. Furthermore, lysosomal exocytosis was defective in TRPML1 KO cells. 
Additionally, TRPML1 induced lysosomal exocytosis was shown to depend on the presence of 
the lysosomal specific phosphoinositide PI(3,5)P2, suggesting that the production of PI(3,5)P2 






Lysosomes, the cell’s recycling centers, are required for cells to eliminate waste materials 
and cellular debris (Kornfeld and Mellman 1989). Recent evidence, however, suggest that 
lysosomes are also involved in mediating membrane trafficking events and cellular signaling 
(Luzio, Pryor et al. 2007; Ballabio and Gieselmann 2009). Accumulated evidence has shown that 
lysosomes undergo exocytosis in response to an increase in intracellular Ca
2+
 levels in most cell 
types across the body (Coorssen, Schmitt et al. 1996; Andrews 2000; Reddy, Caler et al. 2001). 
Lysosomal exocytosis has been shown to play an important role in numerous physiological 
processes, such bone resorption in osteoclasts (Mostov and Werb 1997), plasma membrane 
repair in muscle fibers (Reddy, Caler et al. 2001), neurite outgrowth (Arantes and Andrews 
2006), axonal remyelination in Schwann cells (Chen, Zhang et al. 2012), particle uptake 
(Czibener, Sherer et al. 2006) and antigen presentation (Cresswell 1994) in macrophages. 
Although, the Ca
2+
 dependence of lysosomal exocytosis has been known for years (Rodriguez, 
Webster et al. 1997) the source of Ca
2+
 responsible for providing the Ca
2+
 necessary for 





dependent vesicular trafficking along the late endocytic pathways (Luzio, Rous 
et al. 2000; Luzio, Bright et al. 2007; Luzio, Pryor et al. 2007), it is possible that lysosomes 
themselves provide the Ca
2+
 required for lysosomal exocytosis. However, definitive evidence to 
support this hypothesis is still lacking, and more importantly, the ion channel(s) responsible for 
Ca
2+
 release remain unknown. 
TRPML1 is Ca
2+
 channel on the surface of the lysosomes responsible for the release of 
Ca
2+
 from the luminal side of the lysosomes into the cytoplasm (Cheng, Shen et al. 2010; Dong, 
Shen et al. 2010). Human mutations of TRPML1 cause mucolipidosis type IV (MLIV), a 
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childhood neurodegenerative disorder with lysosomal trafficking defects at the cellular level 
(Bach 2001; Bargal, Avidan et al. 2001; Altarescu, Sun et al. 2002). Several lines of evidence 
suggest that TRPML1 plays a role in mediating lysosomal exocytosis (LaPlante, Sun et al. 2006; 
Dong, Wang et al. 2009). However, they all fail to establish a direct connection between 
TRPML1 activity and lysosomal exocytosis. By using TRPML1-specific activator, with 
TRPML1 KO as controls, I have shown that the acute activation of TRPML1 channel increases 
lysosomal exocytosis. Thus for the first time, my study provides direct evidence to show the 




Macrophage cell culture.  Murine bone marrow derived macrophages (BMMs) were prepared 
and cultured as described previously (Link, Park et al. 2010).  Briefly, bone marrow cells from 
mouse femurs and tibias were harvested and cultured in macrophage differentiation medium 
(RPMI-1640 medium with 10% fetal bovine serum) and 100 unit/ml recombinant colony 
stimulating factor (PeproTech, Rocky Hill, NJ).  After 7 days in culture at 37 °C with 5% CO2, 
the adherent cells (> 95% are expected to be macrophages) were harvested for assays. RAW 
264.7, RAW cells stably-expressing TRPML1 (ML1 overexpression or O/E), and RAW cells 
stably-expressing TRPML1-specific RNAi (ML1 knockdown or KD) (Thompson, Schaheen et 
al. 2007) were kindly provided by Dr. Hanna Fares (University of Arizona). Cells were cultured 
in DMEM/F12 media supplemented with 10% FBS at 37°C and 5% CO2. BMM and RAW 
macrophages were transfected using electroporation (Invitrogen Neon Transfection System) 





-free) once to remove DMEM.  Cells were then centrifuged and the pellets were 
re-suspended in the R buffer. 2 µg of DNA per well was added to the cells, then gently mixed 
41 
 
and placed in the Neon System pipette. The electroporation was performed using program # 6 for 
RAW cells and program # 18 for BMMs, respectively. Transfected cells were then recovered 
with 500 µl of culture media in each plate. 
 
Whole-endolysosome electrophysiology. Endolysosomal electrophysiology was performed in 
isolated endolysosomes using a modified patch-clamp method as described previously (Dong, 
Cheng et al. 2008; Dong, Shen et al. 2010).  Briefly, cells were treated with 1 μM vacuolin-1 for 2-
5h to increase the size of endosomes and lysosomes.  Whole-endolysosome recordings were 
performed on isolated enlarged endolysosomes.  The bath (internal/cytoplasmic) solution contained 
140 mM K-gluconate, 4 mM NaCl, 1 mM EGTA, 2 mM Na2-ATP, 2 mM MgCl2, 0.39 mM CaCl2, 
0.2 mM GTP, and 10 mM HEPES (pH adjusted with KOH to 7.2; free [Ca2+]i was estimated to be 
~ 100 nM using the Maxchelator software (http://maxchelator.stanford.edu/)). The pipette (luminal) 
solution consisted of a ‘Low pH Tyrode’s solution’ with 145 mM NaCl, 5 mM KCl, 2 mM CaCl2, 
1 mM MgCl2, 10 mM HEPES,10 mM MES, and 10 mM glucose (pH 4.6).  All bath solutions were 
applied through a perfusion system to achieve a complete solution exchange within a few seconds.  
Data were collected using an Axopatch 2A patch clamp amplifier, Digidata 1440, and pClamp 10.0 
software (Axon Instruments).  Currents were digitized at 10 kHz and filtered at 2 kHz. All 
experiments were conducted at room temperature (21-23 ºC) and all recordings were analyzed with 
pClamp 10.0, and Origin 8.0 (OriginLab, Northampton, MA).   
 
Flow cytometry. BMMs were trypsinized and washed with PBS before incubation with ML-
SA1(10 μM) at 37°C for 30 min. Cells were then washed and re-suspended in 1% BSA with anti-
mouseLamp1 (1D4B) antibody on ice for 45 min. After this cells were fixed in 2% PFA for 30 min 
and then incubated with Alexa-546 conjugated anti–mouse secondary antibody at room temperature 
for 1h. Macrophages were then re-suspended in 0.5 ml PBS and analyzed on a FACS Flow 
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Cytometer. At least 10,000 cells per experiment were analyzed for the forward angle scatter, the 
right angle scatter, and the fluorescence intensity.  
 
Lysosomal enzyme release/activity. After incubation with ML-SA1 or IgG-RBCs, the culture 
medium was collected for acid phosphatase (AP) activity measurement. AP activity was measured 
using an AP colorimetric assay kit, which uses p-nitrophenyl phosphate (pNPP) as a phosphatase 
substrate that turns yellow at a wavelength of 405 nm when dephosphorylated by AP. Lactate de-
hydrogenase (LDH) activity was measured using a LDH-Cytotoxicity Assay Kit. 
 
Fluorescent microscopy and surface staining. Lamp-1 surface expression was detected in non-
permeabilized WT and TRPML1 KO macrophages. After each treatment, cells were washed with 
ice cold PBS and live cells were stained with 1D4B anti–mouse Lamp1 monoclonal antibody (Iowa 
Hybridoma Bank), which recognizes the luminal epitope of mouse Lamp1. In order to detect 
surface Lamp-1, non-permeablized live cells were first exposed to Lamp-1 primary antibody for 3 
hours, followed by anti-rat secondary antibody for another 2 hours (all at 4°C). Then cells were 
fixed with 4% PFA and stained again with the same antibody overnight to detect the total amount of 
lamp-1 (intracellular + surface). 
 
Real-Time Semi-quantitative PCR.  Total RNA was extracted from bone marrow-derived 
macrophages (BMMs) and dissolved in TRIzol (Invitrogen).  First strand cDNA, synthesized using 
Superscript III RT (Invitrogen), was used for Semi-quantitative PCR (Bio-Rad iQ iCycler) analysis 
of ML1 expression based on the following intron-spanning primer pair: Forward: 






Isolation and characterization of TRPML1 KO bone marrow macrophages 
 To study the role of TRPML1 in lysosomal exocytosis, I isolated monocytes from the 
bone marrow of wild-type (WT) and TRPML1 knockout (KO) mice (Venugopal, Browning et al. 
2007). Monocytes were incubated with macrophage specific growth factors for 5 days at 37°C to 
allow the maturation of monocytes to bone marrow derived macrophages (BMMs) (Chow, 
Downey et al. 2004). TRPML1 KO BMMs contained no detectable level of full-length TRPML1 
transcript, as shown by RT-PCR analysis (Fig. 2.1A). Consistent with this, direct patch-clamping 
of the endolysosomal  membranes showed that ML-SA1, a membrane-permeable TRPML1 
specific synthetic agonist (Shen, Wang et al. 2012), and PI(3,5)P2, an endogenous activator of 
TRPML1 (Dong, Shen et al. 2010), activated whole-endolysosome TRPML1-like currents (IML1) 
in WT, but not TRPML1 KO BMMs (Fig. 2.1B) indicating the absence of a functional TRPML1 
protein in TRPML1 KO BMMs. In contrast, no significant differences were noted in cell 
morphology, cell size, and CD11b (macrophage-specific surface receptor) immunoreactivity 
between WT and TRPML1 KO BMMs (Fig. 2.1C). 
 
Activation of TRPML1 leads to Ca
2+
-dependent lysosomal exocytosis in macrophages 
 To directly investigate the role of TRPML1 in lysosomal exocytosis, I acutely activated 
TRPML1 using ML-SA1 and evaluated lysosomal exocytosis by using Lamp1 surface 
immunostaining with the TRPML1 KO as a negative control.  After lysosomal exocytosis, 
luminal lysosomal membrane proteins can be detected on the extracellular side of the plasma 
membrane. The surface expression of Lamp1 can be detected using a monoclonal antibody 
(1D4B) against a luminal epitope of Lamp1 on non-permeabilized cells (Reddy, Caler et al. 
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2001). To obtain a direct comparison with total (surface + intracellular) Lamp1 proteins, the 
same cells were then permeabilized and stained with the same primary antibody but a distinct 
secondary antibody.  After incubation with the agonist, ML-SA1, for 30 min, WT, but not 
TRPML1 KO BMMs, exhibited a marked increase in Lamp1 staining (Fig. 2.2A) at the cell 
surface, which was shown using the plasma membrane marker DiI-C18(3) (Fig. 2.2B). 
Interestingly, although Lamp1-positive compartments were compensatory up-regulated in 
TRPML1 KO BMMs, much less ML-SA1-induced Lamp1 surface staining was seen in the same 
cells (Fig. 2.2A).  Consistently, flow cytometry-based quantitative analysis demonstrated a ML-
SA1-induced increase in Lamp1 surface staining in WT but not TRPML1 KO BMMs (Fig. 
2.2C&D).  ML-SA1-induced Lamp1 surface staining in WT BMMs was completely abolished 
after pre-treatment with the fast Ca
2+ 
chelator BAPTA-AM (Fig. 2.2C).  Collectively, these 
results suggest that the channel activity of TRPML1 is required for lysosomal exocytosis in 
macrophages in a Ca
2+
-dependent manner.  
  Upon lysosomal exocytosis, lysosomal hydrolytic enzymes, such as acid phosphatases 
(APs), are released into the extracellular medium (Reddy, Caler et al. 2001).  Thus, measuring 
the AP activity of the supernatant can provide a specific readout for lysosomal exocytosis.  
Incubation with ML-SA1 (1 or 10 μM for 15 and 30 min) caused a significant increase in the AP 
release/activity in WT but not TRPML1 KO BMMs (Fig. 2.3A&B). In contrast, no release 
(activity) was detected for the cytosolic enzyme lactate dehydrogenase (LDH) indicating that the 
release of lysosomal enzymes was not due to cell damage (Fig. 2.3C).  Treating cells with Ca
2+
 
ionophore ionomycin induced a large AP release in TRPML1 KO BMMs suggesting that the 
exocytosis machinery was operative (Fig. 2.3D). BAPTA-AM treatment largely abolished ML-





had a minor effect on agonist-induced lysosomal AP release (Fig. 2.3E). This suggests that 
lysosomal exocytosis is triggered by intracellular (lysosomal) TRPML1 mediated Ca
2+
 release 
under physiological conditions.  
 
PI(3,5)P2 is required for TRPML1 induced lysosomal exocytosis 
 The lysosomal specific phosphoinositied PI(3,5)P2 has been shown to be the endogenous 
activator for TRPML1 on the surface of the lysosomes (Dong, Shen et al. 2010). PI(3,5)P2 is 
produced by the kinase PIKfyve in association with the phosphatase FIG4 and the scaffolding 
protein Vac14 (Duex, Nau et al. 2006; Duex, Tang et al. 2006). Genetic or chemical disruption 
of any of these components results in decreased PI(3,5)P2 levels within the cells and 
consequently defective lysosomal related trafficking events (Zolov, Bridges et al. 2012). In 
correlation with the role of TRPML1 in lysosomal exocytosis, macrophages isolated from FIG4 
KO mice were also defective in ML-SA1 induced lysosomal exocytosis (Fig. 2.3F) indicating 
the crucial role of TRPML1 in lysosomal exocytosis.  
 
Lysosomal exocytosis levels correlates with TRPML1 expression/activity  
 I also examined lysosomal exocytosis in the RAW 264.7 macrophage cell line as well as 
RAW cell lines stably expressing TRPML1 (ML1 overexpression or O/E) or TRPML1-specfic 
RNAi (ML1 knockdown or KD) (Thompson, Schaheen et al. 2007). TRPML1 expression levels 
in these three cell lines were confirmed using whole endolysosome recordings (Fig. 2.4A) and 
RT-PCR analysis (Fig. 2.4B). Interestingly, stably-expressing TRPML1 in RAW 264.7 cells 
(ML1 O/E cells) resulted in a higher level of ML-SA1-induced AP release compared with cells 
expressing only endogenous TRPML1 or stably-expressing TRPML1-specific RNAi (TRPML1 
46 
 
KD cells) (Fig. 2.4C). These findings established a correlation between the expression level and 
channel activity of TRPML1 and lysosomal exocytosis in macrophages.  
Discussion 
 
By using a TRPML1 specific activator and TRPML1 KO cells, for the first time, I 
showed the direct involvement of TRPML1 in lysosomal exocytosis. Several lines of evidence 
suggested TRPML1 plays a role in mediating lysosomal exocytosis. Fibroblast cells obtained 
from MLIV patients were shown to be defective in ionomycin-induced lysosomal exocytosis 
(LaPlante, Sun et al. 2006). However, ionomycin induces Ca
2+
 flux non-physiologically 
independent of any specific ion channels.  Therefore, the effect of ionomycin on lysosomal 
exocytosis could be a secondary observation, since ionomycin presumably provides the Ca
2+
 for 
the activation of SytVII non-physiologically (Rodriguez, Webster et al. 1997; Rodriguez, 
Martinez et al. 1999; Reddy, Caler et al. 2001), thereby bypassing upstream TRPML1 activation. 
Later experiments demonstrated that the heterologous expression of the gain-of-function mutant 
TRPML1 enhanced lysosomal exocytosis in HEK293 cell. These experiments were performed 
using a Ca
2+
-free extracellular solution, hence, the gain-of-function mutant TRPML1 construct 
most likely induced Ca
2+
 release from internal sources (Dong, Wang et al. 2009). In addition, the 
shRNA knockdown of TRPML1 in macrophage cell lines delayed the transport of the Major 
Histocompatibility Complex II (MHCII) from LEL compartments to the plasma membrane in 
response to immune stimulations, a process that has been known to be dependent on lysosomal 
exocytosis (Thompson, Schaheen et al. 2007). Collectively, these data suggest that TRPML1 is 
involved in regulating lysosomal exocytosis; however, all these studies failed to illustrate the 
direct and acute involvement of TRPML1 in lysosomal exocytosis.  
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By using the TRPML1 small molecule specific activator (ML-SA1) (Shen, Wang et al. 
2012), I was able to directly induce lysosomal exocytosis in macrophages by activating the 
endogenous TRPML1. ML-SA1 was also able to induce Lamp-1 whole cell surface staining 
while it had no effect on TRPML1 KO macrophages, illustrating the specificity of ML-SA1. 
Moreover, ML-SA1 induced lysosomal exocytosis was abolished by BAPTA-AM while the 
extracellular EGTA had a minor effect. Collectively, these data indicate that the direct activation 
of TRPML1 on the surface of lysosomes is able to induce lysosomal exocytosis and provides 
definitive evidence that lysosomal Ca
2+
 is responsible for the induction of lysosomal exocytosis. 
TRPML1 activation most likely is one of the last steps in the overall lysosomal exocytosis 
machinery since Ca
2+
 is required post SNARE complex formation and is required for the 
activation of SytVII in order to facilitate fusion (Chapter I).  
Although it is clear that lysosomes can undergo Ca
2+
 dependent exocytosis, it is not clear 
what percentage of the total lysosome population can be docked and undergo exocytosis upon 
stimulation in different cell types (Andrews 2000; Jaiswal, Andrews et al. 2002).  It remains to 
be investigated whether all lysosomes respond equally to different stimuli or if there is a 
subpopulation of lysosomes specifically designated for lysosomal exocytosis in different cell 
types. Lysosomes are generally generated through two main processes within cells; endocytosis 
and autophagy (Fig. 2.5). It is not clear what percentage of a cell’s total lysosomal population is 
generated from each pathway, nor is not known if lysosomes generated from one pathway are 
more responsive to lysosomal exocytosis stimulation (Fig. 2.5).  Moreover, lysosomal mobility 
may be a key determinant of lysosomal docking and hence the size of the releasable lysosome 
pool. On the other hand, the nature of the stimulus may determine the size of the releasable pool.  
While activation of TRPML1 promotes post-docking fusion, TFEB regulates both lysosomal 
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docking and fusion (Medina, Fraldi et al. 2011).  In NRK and MEF cells, under normal 
conditions, only about 10-15% of total lysosomal β-hexosaminidase can be released by 
ionomycin within minutes (Rodriguez, Webster et al. 1997).  In macrophages, however, up to 
40-50% of total lysosomal acid phosphatases were releasable by ionomycin (Fig. 2.3 D).  As 
lysosomal enzyme release is an accumulative assay, a high level of lysosome mobility known to 
be associated with macrophages (Mrakovic, Kay et al. 2012) may account for the observed 
differences in the releasable pool.  An outstanding question is whether an increase in the fusion 
of lysosomes with the plasma membrane has any feedback effects that could potentially facilitate 
lysosomal mobility and docking.  Even more generally, how do cells determine the size, location, 
and number of lysosomes?  It appears that the nutrient-sensing machinery in the lysosome, 
including mTOR and TFEB, plays a critical role in regulating these basic parameters for 
lysosomes (Settembre, Fraldi et al. 2013).  
Emerging data in the past decade has changed the traditional view of lysosomes 
dramatically. Lysosomes were originally thought to be the dead-end of degradation pathways, 
however, recent data has illustrated that they play an active role in several cellular processes.  
The discovery of lysosomal exocytosis demonstrated that, unlike other cellular organelles, 
lysosomes are extremely dynamic compartments in the cell. They are constantly derived through 
endocytosis and/or autophagic pathways via the maturation of the late endosome or 
autophagosomes. Meanwhile they are consumed through lysosomal exocytosis where they fuse 
with the plasma membrane. It is critical for cells to maintain a balance between these two 
processes, endocytosis and exocytosis, as defects in either of them has been shown to result in an 





Figure 2.1 Isolation of TRPML1 KO macrophages.  
(A) RT-PCR analysis of wild-type (WT) and TRPML1 KO (ML1 KO) bone marrow-derived 
macrophages (BMMs) using a primer pair targeting the deleted region (exons 3, 4, and 5) of the 
TRPML1 gene. The housekeeping gene L32 served as a loading control. (B) ML-SA1 and 
PI(3,5)P2 robustly activated endogenous whole endolysosome ML1-like currents in WT but not 
ML1 KO BMMs. (C) Mature monocytes isolated from WT and ML1 KO mouse bone marrow 
had similar morphological characteristics, as revealed by CD11b (mature macrophage-specific 
surface receptor) staining.  Scale bar = 30 µm.  Isolated monocytes were cultured in DMEM/F12 
and recombinant colony stimulating factor for 5-7 days and then fixed and stained with anti-
CD11b antibody and DAPI to show cell’s nucleus (blue). Electrophysiology experiments in 








Figure 2.2 TRPML1 activation induces Lamp-1 translocation to the plasma membrane   
(A) ML-SA1 (10 mM for 30 min) treatment resulted in localization of Lamp1 (red) on the 
plasma membrane in non-permeabilized WT but not ML1 KO BMMs. Lamp1 surface expression 
was detected using an antibody recognizing a luminal epitope (1D4B). After the cells were 
permeabilized, total (cell surface + intracellular; green) Lamp1 proteins were detected using the 
same antibody. Scale bar represents 5 µm. (B) Lamp1 surface staining was co-localized with the 
plasma membrane marker DiI-C18(3).  Scale bar = 5 µm.  (C) Flow cytometric analysis of ML-
SA1-induced Lamp1 surface expression in WT and ML1 KO BMMs. Pre-treatment with 
BAPTA-AM (1 µM for 30 min) completely abolished Lamp1 surface staining in WT BMMs. 












Figure 2.3 TRPML1 activation mediated Ca
2+
 induced lysosomal exocytosis and the release 
of lysosomal content into the extracellular space.  
(A & B) ML-SA1 (0.1-10 µM for 15 or 30 min) treatment increased the release of lysosomal 
enzymes into the culture medium in BMMs.  The activity of lysosomal enzyme acid phosphatase 
(AP) was determined using an AP activity colorimetric assay kit.  The data are presented as the 
percentage of the activity of the released vs. total (released + cell-associated) enzymes. (C) Lack 
of an effect of ML-SA1 on the release of cytosolic enzyme LDH. (D) Ionomycin-induced 
lysosomal enzyme acid phosphatase (AP) release/activity was comparable, but slightly reduced 
in ML1 KO BMMs. The data are presented as the percentage of the activity of the released 
enzymes versus total (released + cell-associated) enzymes.  (E) The effects of intracellular and 
extracellular Ca
2+
 on ML-SA1 (10 µM for 30 min) -induced lysosomal AP release.  BAPTA-AM 
(500 nM) and EGTA (2 mM with no added extracellular Ca
2+
) were used to chelate intracellular 
and extracellular Ca
2+
, respectively. (F) ML-SA1 induced lysosomal AP release was reduced in 




















Figure 2.4 Lysosomal exocytosis correlates with TRPML1 activity/expression.  
(A) ML-SA1-activated whole-endolysosome TRPML-like currents in RAW 264.7 macrophage 
cell lines, RAW cells stably expressing ML1-GFP (ML1 overexpression or O/E), and RAWcells 
stably expressing ML1-specific RNAi (ML1 knockdown or KD). (B) Real-time RT-PCR 
analysis of ML1 RNA expression level (relative to L32) in RAW macrophages (n = 3 batches of 
independent experiments for each cell type). (C) Lysosomal AP release in RAW 264.7, ML1 
O/E, and ML1 KD RAW macrophages. The amount of AP release correlates with the 
expression/activity of TRPML1 in macrophages. Electrophysiology experiments in section A 










Figure 2.5 The role of TRPML1 in Ca
2+
 mediated lysosomal exocytosis   
Lysosomal exocytosis is a Ca
2+
-dependent process.  Early endosomes are generated from nascent 
endocytic vesicles via endocytosis. Autophagosomes are generated via autophagy.  
Autophagosomes and endosomes then fuse with lysosomes, which contain high Ca
2+
 
concentration (~ 0.5 mM). Therefore, both autophagy and endocytosis contribute to maintaining 
cellular lysosome populations. The generation of PI(3,5)P2 and the activation of TRPML1 
mediates lysosomal Ca
2+
 release, leading the induction of lysosomal exocytosis in response to 
different cellular stimuli. The induction of lysosomal exocytosis consumes cellular lysosomes, 
thus, keeping a balance between pathways leading to lysosome generation and lysosome 
















TRPML1 REGULATES LARGE PARTICLE UPTAKE IN 
MACROPHAGES VIA LYSOSOMAL EXOCYTOSIS 
 
Abstract 
Particle ingestion during phagocytosis depends on the extension of plasma membrane and 
the formation of filopodia-like structures around the particle to be ingested. Recent evidence 
indicates that membrane extension depends on the delivery of lysosomal membrane, through 
Ca
2+
 dependent lysosomal exocytosis, to the site of particle uptake to compensate for the plasma 
membrane that is lost during phagosome formation. However, the source of Ca
2+
 and the Ca
2+
-
channel(s) responsible for Ca
2+
 release during particle uptake are not fully characterized. Here I 
identified TRPML1 as the key lysosomal Ca
2+
 channel regulating particle uptake in 
macrophages. Particle ingestion is inhibited by a synthetic TRPML1 blocker and is defective in 
macrophages isolated from TRPML1 knockout mice. Furthermore, TRPML1 overexpression and 
TRPML1 agonists facilitate particle uptake. Using time-lapse confocal imaging, we found that 
particle binding triggered TRPML1-mediated lysosomal Ca
2+ 
release specifically at the site of 
uptake, rapidly delivering TRPML1-resident lysosomal membranes to nascent phagosomes; thus, 
providing membranes necessary for pseudopod extension, leading to clearance of senescent cells 





Macrophages participate in tissue remodeling and cellular clearance by engulfing large 
extracellular particles, such as apoptotic cells or senescent red blood cells (RBCs) (Wynn, 
Chawla et al. 2013), through a highly regulated process called phagocytosis (Aderem and 
Underhill 1999). Particle binding to specific cell surface receptors, such as IgG Fc receptors, 
triggers a cascade of signaling events resulting in a rapid extension of plasma membrane around 
the particle(s) (Niedergang and Chavrier 2004). Plasma membrane extensions, called 
plasmalemmal pseudopod, form phagocytic cups to ingest particles into vacuole-like structures 
called phagosomes within several minutes after particle binding (Flannagan, Jaumouille et al. 
2012).  Nascent phagosomes then undergo membrane fusion and fission events, collectively 
called phagosomal maturation, in a time course of tens of minutes to become phagolysosomes to 
mediate particle digestion (Vieira, Botelho et al. 2002). Although a large amount of plasma 
membrane is internalized during phagocytosis, paradoxically, the overall surface area of the 
phagocytosing cells does not decrease (Huynh, Kay et al. 2007), and indeed increases 
significantly before the closing of the phagocytic cups (Holevinsky and Nelson 1998).  
Consistently, membrane fusion machinery is shown to be required for phagosome 
formation/biogenesis and efficient phagocytosis (Hackam, Rotstein et al. 1998). A substantial 
amount of membrane from intracellular compartments is added to the cell surface at the sites of 
particle uptake (so called “focal” exocytosis) (Braun, Fraisier et al. 2004; Czibener, Sherer et al. 
2006). 
Recycling endosomes have been shown to be a supply of intracellular membrane for 
phagosome formation and particle uptake in a Vesicle-Associated Membrane Protein 3 
(VAMP3)-dependent manner (Allen, Yang et al. 2002).  More recently, lysosomes have been 
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identified as another major source of intracellular membrane required for particle uptake, 
particularly under high load conditions, i.e., when large (> 5 µm) and/or multiple small particles 
are ingested by a single phagocyte (Braun, Fraisier et al. 2004; Czibener, Sherer et al. 2006). 
Under such conditions, lysosomes are involved in the very early steps of phagosome 
biogenesis/formation, prior to the closing of the phagocytic cups.  Fusion of lysosomes with the 
plasma membrane (lysosomal exocytosis) and the delivery of lysosomal membranes/proteins to 
the surface of the newly formed phagosomes are observed at the site of particle ingestion. 
Manipulations blocking lysosomal exocytosis significantly reduces particle uptake in 
macrophages (Braun, Fraisier et al. 2004; Czibener, Sherer et al. 2006). Ca
2+
 is the only known 
trigger that has been identified for lysosomal exocytosis (Andrews 2000). However the source of 
Ca
2+
 involved in this process and the ion channel(s) responsible for Ca
2+
 release are not fully 
characterized.  
Transient Receptor Potential Mucolipin-1 (TRPML1) is a member of the TRP cation 
channel superfamily, and is primarily localized on the lysosome membrane (Cheng, Shen et al. 
2010). Human mutations of TRPML1 cause mucolipidosis type IV (MLIV), a childhood 
neurodegenerative disorder with lysosomal trafficking defects at the cellular level (Amir, 
Zlotogora et al. 1987; Bach 2001; Altarescu, Sun et al. 2002; Bargal, Goebel et al. 2002; Cheng, 
Shen et al. 2010).  In a Drosophila model of MLIV, it has been proposed that the defective 
clearance of late apoptotic neurons by phagocytes contributes significantly to the 
neurodegeneration (Venkatachalam, Long et al. 2008). TRPML1 has been shown to be a Ca
2+
-
permeable channel on the lysosomal membrane conducting the flow of Ca
2+
 from the lysosome 
lumen into the cytosol {Cheng, 2010 #121; Dong, 2012 #122}. In the previous chapter, I 
demonstrated that TRPML1 plays a crucial role in regulating lysosomal exocytosis in 
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macrophages (Chapter II). Therefore, I hypothesized that TRPML1 could potentially regulate 
particle ingestion and cellular clearance by promoting lysosomal Ca
2+
 release and thus, trigger 




Mouse lines.  The generation and characterization of ML1 (Venugopal, Browning et al. 2007) and 
FIG4 KO mice (Chow, Zhang et al. 2007) have been described previously.  Animals were used 
under approved animal protocols and Institutional Animal Care Guidelines at the University of 
Michigan. 
 
Macrophage cell culture.  Murine BMMs were prepared and cultured as described previously 
(Link, Park et al. 2010).  Briefly, bone marrow cells from mouse femurs and tibias were harvested 
and cultured in macrophage differentiation medium (RPMI-1640 medium with 10% fetal bovine 
serum (FBS) and 100 unit/ml recombinant colony stimulating factor (PeproTech, Rocky Hill, NJ).  
After 7 days in culture at 37 °C with 5% CO2, the adherent cells (> 95% are expected to be 
macrophages) were harvested for assays. RAW 264.7, RAW cells stably-expressing ML1 (ML1 
overexpression or O/E), and RAW cells stably-expressing ML1-specific RNAi (ML1 knockdown or 
KD) (Thompson, Schaheen et al. 2007) were kindly provided by Dr. Hanna Fares (University of 
Arizona) and cultured in DMEM/F12 media supplemented with 10% FBS at 37°C and 5% CO2. 
BMM and RAW macrophages were transfected using electroporation (Invitrogen Neon 
Transfection System) according to the manufacturer procedures.  Briefly, cells were harvested and 




-free) once to remove DMEM.  Cells were then centrifuged and 
the pellets were re-suspended in the R buffer.  2 µg of DNA per well was added to the cells, which 
were gently mixed and placed in the Neon System pipette.  The electroporation was performed 
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using program # 6 for RAW cells and program # 18 for BMMs, respectively.  Transfected cells 
were then recovered with 500 µl of culture media in each plate. 
Phagocytosis assay.  Sheep RBCs (Lampire Biological Laboratories) were washed twice with PBS 
and then fixed with 4% paraformaldehyde (PFA) overnight at 4°C in an end-over-end rotator. Free 
aldehyde groups were quenched by re-suspension in PBS containing 100 mM glycine for 30 minutes 
at 4°C. RBCs were opsonized with rabbit IgG antibody (Equitech-Bio, Inc) at 37°C for 1h.  
Phagocytosis was initiated by adding IgG-RBCs onto adherent BMMs at a ratio of 50:1 (RBC: BMM).  
To synchronize binding and internalization, IgG-RBCs were centrifuged at 300 rpm for 3 minutes 
together with adherent BMMs.  BMMs were placed at 37°C with 5% CO2 for various time points (15- 
90 minutes).  Non-ingested IgG-RBCs were lysed by incubating the cells with water (1 ml) for 2-3 min 
at 4°C (Chow, Downey et al. 2004).  RBC-containing BMMs were fixed in 2% PFA and stained with 
goat-anti rabbit IgG AlexaFluor488 (1:500 dilution, Invitrogen).  Approximately 150-200 BMMs were 
typically analyzed for each experiment.  Ingested RBCs were counted by experimenters who were 
blinded to the genotype and treatment.  
 
Fluorescence and time-lapse imaging. Live imaging of RBC uptake by BMMs was performed on 
a heated stage using a Spinning Disk confocal imaging system consisting of an Olympus IX81 
inverted microscope, a 100X Oil objective NA 1.49 (Olympus, UAPON100XOTIRF), a CSUX1 
scanner (Yokogawa), an iXon EM-CCD camera (Andor), and MetaMorph Advanced Imaging 
acquisition software v.7.7.8.0 (Molecular Devices). For Lamp1 detection, BMMs were fixed with 
4% PFA, and permeabilized with 0.03% Triton X-100, then stained with 1D4B anti–mouse Lamp1 
monoclonal antibody (Iowa Hybridoma Bank). For phalloidin staining of phagosomes, BMMs were 
incubated for 10 minutes with IgG-RBCs, fixed with 4% PFA, permeabilized with 0.03% Triton X-
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100 for 5 min, and labeled with phalloidin- Alexa-Fluor633 (Invitrogen) for 30 minutes. All images 
were taken with the 100X objective of a Leica (TCS SP5) confocal microscope. 
Whole-cell electrophysiology. Whole-cell recordings were performed as described previously. The 
pipette solution contained 147 mM Cs,120 mM methane-sulfonate, 4 mM NaCl, 10 mM EGTA, 2 
mM Na2-ATP, 2 mM MgCl2, and 20mM HEPES (pH 7.2; free [Ca2+]i < 10 nM). The standard 
extracellular bath solution (modifiedTyrode’s solution) contained 153 mM NaCl, 5 mM KCl, 2 mM 
CaCl2, 1 mM MgCl2, 20 mMHEPES, and 10 mM glucose (pH 7.4). BMMs were incubated with 
IgG-RBCs at 4 °C for 20 minutes then placed at 37°C with 5% CO2 for 5~10 minutes before 




 imaging.   Cellswere loaded with 5 M Fura-2 AM in the culture medium at 37 °C 
for 60 minutes. Fluorescence was recorded at different excitation wavelengths using an 
EasyRatioPro system (PTI).  Fura-2 ratios (F340/F380) were used to monitor changes in intracellular 
[Ca
2+
] upon stimulation.  Ionomycin (1 M) was added at the conclusion of all experiments to 
induce a maximal response for comparison. 
H&E Staining. Hematoxylin and eosin (H&E) staining was performed in 5 μm slice sections 
prepared from paraffin-embedded spleen tissues using microtome. The tissues were fixed with 4% 
PFA upon heart perfusion in 10 -12 week old WT and ML1 KO mice. 
Cell death analysis in brain slices. Brain slices were stained with propidium iodide (PI; membrane 
impermanent dye only enters the dying cells) and analyzed with confocal microscopy. Briefly, fresh 
mouse brains were sectioned into 300 µm thick slices with a vibratome sectioning system. 
Immediately after cutting the sections, slices were washed with cold (4°C) HBSS solution, then 
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incubated with PI (20µg/ml) at 37°C for 15 minutes, fixed in 4% paraformaldehyde for another 30 
minutes, then mounted on the glass slides. To avoid damage caused by tissue preparation, images 
were taken 100 µm underneath the surface of the slice sections. 
Measurement of splenic iron content. Spleens were completely digested in 3M hydrocholoric 
acid/10% tricholroacetic acid at 65°C overnight. Samples were then centrifuged in order to 
precipitate any non-digested materials. The ionic composition of the supernatant was analyzed 
using a Thermo Scientific Finnigan Element inductively coupled with a plasma-high resolution 
mass spectrometer (ICP-HRMS). 
Data analysis. Data are presented as the mean ± standard error of the mean (SEM). Statistical 




Expression of TRPML1 is necessary for efficient uptake of large particles in macrophages. 
 
Among the professional phagocytes, I chose macrophages to study the effect of TRPML1 
on particle uptake. Unlike other professional phagocytes, such as neutrophils, macrophages have 
a much longer life cycle and reside in several tissues through the body. More importantly, they 
actively participate in removing apoptotic bodies in different tissues, such as spleen and brain, 
and they have a dynamic role in inflammatory responses in those tissues (Chawla 2010). Thus, I 
hypothesized that macrophages must have established machinery for the uptake of large 
particles. To study the role of TRPML1 in particle uptake/ingestion, I isolated monocytes from 
the bone marrow of wild-type (WT) and TRPML1 knockout (KO) mice. Monocytes were 
incubated with macrophage specific growth factors for 5 days at 37°C to allow for the maturation 
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of monocytes to bone marrow derived macrophages (BMMs) (Chow, Downey et al. 2004). The 
initial characterization of TRPML1 KO macrophages was shown in chapter II (Fig. 2.1). 
To investigate the role of TRPML1 in particle ingestion, WT and TRPML1 KO BMMs 
were exposed to IgG-opsonized sheep red blood cells (IgG-RBCs), all about 5 µm in size, for 
different periods of time (15-90 min; Fig. 3.1A-C). IgG-RBC uptake was quantified for at least 
150 BMMs per time point for each genotype. Un-ingested IgG-RBCs were hypotonically lysed 
by briefly (1-2 min) incubating the cells in 4ºC water. Ingested IgG-RBCs were counted 
individually by experimenters who were blind to the genotypes and experimental conditions. 
Distribution histograms were created at each time point for each genotype based on the number 
of ingested particles per cell. Thresholds were set (4 to 10 or more particles per cell) based on the 
cell type and particle size in order to compare the phagocytic capability (Fig. 3.1B). Based on a 
threshold of 10 or more (10+) IgG-RBCs per BMM (Fig. 3.1B), a significant difference in 
particle uptake was noted between WT and TRPML1 KO BMMs. Uptake defects were more 
severe as time progressed. After 90 minutes, approximately 50% of WT, but less than 20% of 
TRPML1 KO BMMs contained 10+ internalized IgG-RBCs (Fig. 3.1A-C). The progressive 
inhibition of uptake caused by TRPML1 deficiency suggested that TRPML1 is necessary for the 
ongoing uptake of large particles, which is consistent with the reported, preferential requirement 
of lysosomal membrane delivery for large particle uptake. 
To further probe this possibility, BMMs were tested for their ability to ingest different-
sized IgG-opsonized polystyrene beads. Interestingly, while the internalization of 3 μm beads (a 
threshold of 10+ 3μm beads set for BMMs) was similar for WT and TRPML1 KO BMMs, 
uptake of 6μm beads (a threshold of 4+ 6-μm-beads for BMMs) was significantly reduced in 
TRPML1 KO BMMs at all-time points. Uptake of zymosan particles (diameter = 2-3 μm) was 
64 
 
also normal for TRPML1 KO BMMs (Fig. 3.1D).  These observations are reminiscent of the 
particle size-dependent uptake defect seen in SytVII KO BMMs. Taken together, these results  
suggest that TRPML1 is required for efficient uptake of large particles, i.e., when the need for 
membranes from internal sources is high. 
 
The channel activity of TRPML1 induces large particle uptake in macrophages. 
Next, we investigated whether increasing the expression/activity of TRPML1 can 
facilitate particle uptake in macrophages. Incubating WT BMMs with a TRPML agonist, ML-
SA1 (1-10 µM), for 15 minutes caused more than a two-fold increase in the percentage of cells 
containing 10+ IgG-RBCs. In contrast, the increase was negligible for TRPML1 KO BMMs 
(Fig. 3.2A). Moreover, heterologous expression of TRPML1-GFP in addition to ML-SA1 
treatment in TRPML1 KO BMMs was sufficient to restore the uptake efficiency to the same 
level as WT BMMs. Meanwhile, the expression of TRPML1-KK-GFP, a non-conducting pore 
mutant of TRPML1, failed to restore the particle uptake capacity in TRPML1 KO BMMs (Fig. 
3.2B). These results established a positive correlation between the channel activity of ML1 and 
IgG-RBC uptake. 
We also examined particle uptake in RAW 264.7 macrophage cell lines, as well as RAW 
cell lines stably expressing TRPML1 (TRPML1 overexpression or O/E) or TRPML1-specfic 
RNAi (TRPML1 knockdown or KD) (Chapter II, Fig. 2.4). Interestingly, particle uptake 
efficiency in these lines correlated with their respective expression levels of TRPML1 with an 
even greater correlation in the presence of ML-SA1 (Fig. 3.2C). The threshold of 5+ ingested 
IgG-RBCs was set to reflect the smaller size of RAW cells compared to BMMs. While 
approximately 30% of the ML1 O/E cells ingested 5+ IgGRBCs, fewer than 10% of ML1 KD 
cells contained 5+ IgG-RBCs (Fig. 3.2C). Collectively, these data suggest that the efficiency of 
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particle uptake in macrophages is positively-correlated with the expression level and channel 
activity of TRPML1. 
 
The inhibition of TRPML1 activity inhibited large particle uptake in macrophages. 
 
To further investigate the role of TRPML1 in particle uptake, we employed 
pharmacological tools to acutely inhibit the channel function of TRPML1. Using a Ca
2+
 imaging-
based high-throughput screening method, we identified a synthetic small molecule inhibitor for 
TRPML1 (Mucolipin Synthetic Inhibitor 1 or ML-SI1). Using whole-endolysosome patch-clamp 
recordings, we confirmed that ML-SI1 strongly inhibited basal, ML-SA1 or PI(3,5)P2-activated 
IML1 (Fig. 3.3A&B). In contrast, ML-SI1 failed to inhibit PI(3,5)P2-activated whole-
endolysosome TPC2 currents (Fig. 3.3C), demonstrating a relative specificity. Additionally, 
similar results were obtained using GCaMP3-ML1based Ca
2+
-imaging system (Shen, Wang et al. 
2012) where ML-SI1 was able to completely block ML-SA1 induced lysosomal Ca
2+
 release 
(Fig. 3.3D). In addition, ML-SI1 was able to mostly inhibit TRPML1 current at very low 
concentrations, but it completely inhibited TRPML1 current at 10 µM (Fig. 3.3E). In correlation 
with these data, ML-SI1 (10 μM) treatment was sufficient to reduce IgG-RBC uptake in WT 
BMMs to the same level as TRPML1 KO BMMs without significantly affecting the uptake in 
TRPML1 KO cells (Fig. 3.3F). Collectively, these results illustrate that the channel activity of 
TRPML1 is required for large particle uptake in macrophages. 
 
TRPML1 is rapidly recruited to phagocytic cups and nascent phagosomes of large particles 
To investigate the mechanisms by which TRPML1 contributes to particle uptake, I 
performed time-lapse confocal microscopy of live RAW cells during the particle uptake process. 
I observed that TRPML1-GFP was rapidly (within 1-3 min) recruited to the site of phagosome 
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formation during the uptake of 6 μm beads (Fig. 3.4A). Strikingly, in contrast to large particle 
uptake, TRPML1-GFP was not recruited to the site of phagosome formation during the uptake of 
3 μm beads (Fig. 3.4B). These data clearly demonstrate that different signaling mechanisms are 
involved in the uptake of different size particles.  
Next, I compared the localization of TRPML1 with other lysosomal membrane proteins 
known to be involved in phagosome formation and maturation. As mentioned before, SytVII is a 
lysosomal Ca
2+
 sensor shown to be involved in lysosomal exocytosis (Rodriguez, Webster et al. 
1997; Rodriguez, Martinez et al. 1999; Reddy, Caler et al. 2001). In macrophages, SytVII has 
been shown to be recruited to the nascent phagosomes upon particle binding (Czibener, Sherer et 
al. 2006). BMMs isolated from SytVII KO mice exhibit a similar phenotype as TRPML1 KO 
BMMs; they have been shown to be defective in large particle uptake and the defect is 
proportional to the particle size (Czibener, Sherer et al. 2006). Within 2–3 minutes after exposing 
the RAW cells to IgG-RBCs, both TRPML1-GFP and SytVII-mCherry appeared on the 
membranes of nascent phagosomes (Fig. 3.4C). TRPML1-GFP and SytVII-mCherry positive 
(lysosomal) tubules were then observed wrapping themselves around the newly formed 
phagosomes. The recruitment kinetics was similar for both proteins (Fig. 3.4C). 
Next I compared the dynamics of TRPML1 to other known proteins involved in 
phagosome maturation (Vieira, Botelho et al. 2002). Similar to TRPML1 and SytVII, lysosome-
associated membrane protein 1 (Lamp-1) was also rapidly recruited to newly formed large-
particle-containing phagosomes in RAW macrophages BMMs (Fig. 3.5). The recruitment of 
TRPML1 and Lamp1 to forming phagosomes occurred prior to the recruitment of Rab5, an early 
phagosome maturation marker, and Rab7, a late phagosome maturation marker (Vieira, Botelho 
et al. 2002) (Fig. 3.5). In correlation with this, the recruitment of lysosomal membrane proteins 
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TRPML1 and Lamp-1 occurred prior to lysosomal acidification, as illustrated using acid 
sensitive dye LaysoTraker (Fig. 3.5). Consistently, during large particle uptake, the newly 
formed phagosomes (5 minutes after particle binding) in WT BMMs, compared with TRPML1 
KO BMMs, contained significantly more Lamp-1 proteins (Fig. 3.6A). Phagosomes are still 
wrapped with polymerized actin within 5–10 minutes after particle binding (Fig. 3.6A) 
suggesting that TRPML1 and Lamp-1 are recruited to the newly formed phagosomes before the 
phagosomes enters the phagosomal maturation pathway (Vieira, Botelho et al. 2002). 
Collectively, these results suggest that during large particle uptake, recruitment of TRPML1 and 
other lysosomal membrane proteins occurred in the very early stages of phagosome formation, 
prior to Rab5- mediated early phagosome maturation.  
To further confirm the presence of TRPML1 on the newly formed phagosomes, we 
developed a patch-clamp method to directly record from phagosomal membranes (Fig. 3.7A-B).  
Phagosomes were isolated from Lamp1-GFP or TRPML1-GFP-transfected RAW cells after 
exposure to IgG-RBCs or beads for 5 min. In Lamp1-GFP-transfected RAW cells, bath 
application of PI(3,5)P2 (100 nM) or ML-SA1 (25 µM) readily activated endogenous whole-
phagosome TRPML1-like currents (Fig. 3.7C). Much larger whole-phagosome ML-SA1-
activated currents were seen in TRPML1-GFP-transfected RAW cells. In WT BMMs, whole-
phagosome ITRPML1 was activated by ML-SA1, and inhibited by ML-SI1 (Fig 3.7D).  These 
results thus provide functional evidence that TRPML1 is recruited to nascent phagosomes.   
 




TRPML1 is a lysosomal Ca
2+
 channel suggested to be involved in the release of Ca
2+
 
from the lysosomal luminal side into the cytoplasm (Cheng, Shen et al. 2010). Additionally, 
68 
 
large particle uptake in macrophages has suggested to be Ca
2+
 dependent (Czibener, Sherer et al. 
2006). Therefore, I hypothesized that TRPML1 could regulate large particle uptake by mediating 
lysosomal Ca
2+
 release, thus, regulating lysosomal exocytosis. Consistent with this idea 
pretreatment of BMMs with a membrane-permeable, fast Ca
2+
 chelator, BAPTA-AM, 
significantly inhibited particle uptake in WT macrophages after 90 minutes, but to a lower 
degree in TRPML1 KO cells (Fig. 3.8A). In a separate experiment, large particle uptake was 
evaluated after exposing macrophages to different concentrations of the fast Ca
2+
 chelator 
BAPTA-AM and the slow Ca
2+
 chelator EGTA-AM (Fig. 3.8B). BAPTA-AM was able to inhibit 
large particle uptake at lower concentrations, however, EGTA-AM failed to block large particle 
uptake even at higher concentrations (Fig. 3.8B). This illustrated that the Ca
2+
 required for large 
particle uptake is most likely provided from a local source very close to the sites of particle 
uptake and very close to the site of lysosomal exocytosis.  
Although lysosomal membrane fusion events are presumed to be dependent on  
lysosomal Ca
2+
 release in the close vicinity of fusion spots, direct evidence has yet to be reported 
(Pryor, Mullock et al. 2000; Piper and Luzio 2004; Czibener, Sherer et al. 2006; Luzio, Bright et 
al. 2007). To directly observe lysosomal Ca
2+
 during particle uptake we used a lysosome-
targeted genetically encoded Ca
2+
 indicator, GCaMP3-TRPML1, to specifically measure 
lysosomal Ca
2+
 release in intact cells (Shen, Wang et al. 2012). Transient and localized Ca
2+
 
increases, measured with GCaMP3 fluorescence changes, were observed preferentially at the 
uptake sites of SytVII-mCherry-positive lysosomes within several minutes of particle binding for 
both IgG-RBCs (Fig. 3.9A). In contrast, little or no GCaMP3 fluorescence increase was seen in 
other areas of the phagocytosing macrophages within the same time course. These results suggest 
that particle binding induces TRPML1-mediated lysosomal Ca
2+
 release locally at the site of 
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uptake. In contrast, in RAW264.7 cells doubly transfected with SytVII-mCherry and GCaMP3-
TRPML1-KK (a non-conducting pore mutation), no Ca
2+
 release was observed at the site of 
particle uptake (Fig 3.9B). These results, for the first time, illustrated that particle binding 
induces TRPML1-mediated lysosomal Ca
2+
 release locally at the site of particle uptake.   
 
TRPML1 regulates particle uptake via lysosomal exocytosis  
 
Lysosome fusion with the plasma membrane (lysosomal exocytosis) has been shown to 
be required for the uptake of large particles in macrophages (Braun, Fraisier et al. 2004; Braun 
and Niedergang 2006; Czibener, Sherer et al. 2006; Huynh, Kay et al. 2007). Also, TRPML1 has 
been shown to be involved in lysosomal exocytosis in macrophages (Chapter II). I sought to 
evaluate particle induced lysosomal exocytosis by directly investigating the insertion of 
TRPML1 onto the plasma membrane during particle uptake. Because current antibodies are 
inadequate for detecting endogenous TRPML1 proteins, we developed a whole-cell patch-clamp 
method to ‘‘detect’’ the plasma membrane insertion of TRPML1 during particle uptake. This 
electrophysiology-based ‘‘exocytosis assay’’ provides temporal resolution far superior to other 
exocytosis/secretion assays. In order to facilitate detection (by decreasing the turnover time of 
TRPML1 at the plasma membrane), we used dynasore, a cell permeant dynamin inhibitor 
(Macia, Ehrlich et al. 2006), to block endocytosis presumed to be coupled with focal exocytosis 
(Braun and Niedergang 2006). Large ML-SA1-induced whole-cell TRPML1-like currents were 
observed upon exposure of WT BMMs to IgG-RBCs for 10 minutes in the presence of dynasore 
(Fig. 3.10A&B). In contrast, no significant ML-SA1-induced whole-cell currents were observed 
in RBC-treated TRPML1 KO BMMs, or WT BMMs treated with dynasore alone (Fig. 
3.10A&B). IgG-RBC-induced whole-cell IML1 was completely inhibited by BAPTA-AM 
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pretreatment (Fig. 3.10B), suggesting that TRPML1 insertion in to the plasma membrane is Ca
2+
 
dependent.   
To further investigate the role of TRPML1 in lysosomal exocytosis and particle uptake, 
BMMs were exposed to IgG-RBCs for various lengths of time and lysosomal enzyme acid 
phosphatase (AP) release into the surrounding media was measured as the readout for lysosomal 
exocytosis. Compared with WT BMMs, TRPML1 KO cells exhibited significantly less IgG-
RBC-induced AP release (Fig. 3.10C). This difference was abolished by either BAPTA-AM or 
inhibition of TRPML1 using ML-SI1 (Fig. 3.10C).  
To directly investigate whether the involvement of TRPML1 in large particle uptake is 
mediated by lysosomal exocytosis, I assessed particle uptake upon increasing the expression 
level and channel activity of TRPML1 while simultaneously blocking lysosomal exocytosis. 
Three approaches were employed to block lysosomal exocytosis. First, lysosomal exocytosis and 
particle uptake were inhibited by dominant-negative (DN) forms of SytVII (Reddy, Caler et al. 
2001). I found that ML-SA1-induced large particle uptake was significantly reduced in SytVII-
DN-transfected TRPML1 O/E RAW cells (Fig. 3.11A). Second, VAMP7 is a lysosomal SNARE 
protein required for lysosome-plasma membrane fusion (Braun, Fraisier et al. 2004). VAMP7 
belongs to the Longin family of SNARE proteins characterized by the presence of an auto-
inhibitory domain at their N terminus (Martinez-Arca, Rudge et al. 2003). Overexpression of the 
Longin domain of VAMP7 alone in macrophages is known to exert a dominant negative effect 
on both lysosomal exocytosis and particle uptake (Braun, Fraisier et al. 2004). ML-SA1 
treatment failed to enhance particle uptake in cells transfected with Longin-GFP, including ML1 
O/E RAW cells (Fig. 3.11B), whereas overexpression of VAMP7-GFP had no inhibitory effect. 
Third, lysosomal exocytosis can also be reduced by treating the cells with colchicine, a known 
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inhibitor of microtubule polymerization (Lee, Mason et al. 2007). I found that colchicine 
treatment significantly inhibited ML-SA1-induced large particle uptake (Fig. 3.11C) in TRPML1 
O/E RAW cells. Taken together, these data suggest that TRPML1 participates in large particle 
uptake by regulating Ca
2+
-dependent lysosomal exocytosis in macrophages. The residual particle 
uptake in TRPML1 KO BMMs was further inhibited by tetanus toxin (TeNT, an inhibitor of 
several VAMP proteins including VAMP3), which is consistent with an additional contribution 
of membranes/exocytosis from recycling endosomes as reported previously (Fig. 3.11D). 
 
TRPML1 deficiency results in defective clearance of senescent and apoptotic cells in vivo. 
 
Senescent RBCs are normally phagocytosed by macrophages in the red pulp region of the 
spleen, followed by the degradation of their haemoglobin and recycling of iron into the 
circulating blood (Bratosin, Mazurier et al. 1998). Considering that TRPML1 KO BMMs were 
defective in the uptake of large cellular particles, we investigated RBC clearance in the spleens 
of TRPML1 KO mice. In TRPML1 KO spleens, in correlation with other LSDs, Lamp1 
expression was elevated as detected by western blot (Fig. 3.12A) and tissue immunostaining 
(Fig. 3.12B). Additionally, TRPML1 KO mice exhibited enlarged spleens, but had normal 
kidney size compared with WT controls (Fig. 3.12C). This is suggestive of compensatory 
changes secondary to defective clearance of senescent RBCs. Consistently, hematoxylin and 
eosin (H&E) staining of spleen sections revealed an accumulation of RBCs in both white and red 
pulps of TRPML1 KO but not WT spleens (Fig. 3.12D). Accumulation of RBCs in the spleen 
reportedly leads to a buildup of splenic iron stores (Kohyama, Ise et al. 2009). Indeed, Perl’s 
Prussian blue staining (for ferric iron) revealed an accumulation of iron stores in the spleens of 
TRPML1 KO mice, which was largely confined to the red pulp region (Fig. 3.12E). 
72 
 
Consistently, inductively-coupled plasma mass spectrometry (ICP-MS) analysis revealed that 
iron content was selectively increased in the TRPML1 KO spleens (Fig. 3.12F). Taken together, 
these results suggest that RBC clearance is defective in TRPML1 KO mice. Defective 
phagocytosis in the brain may lead to inflammation and microglia (macrophage like cells in the 
brain) activation. Consistently, Iba1, a 17-kDa EF hand protein that is specifically expressed in 
activated macrophage/microglia, was up-regulated in the brain of TRPML1 mice (Fig. 
3.13A&B) in addition to massive cell death observed in the cerebral cortex and hippocampus of 




Using pharmacological, genetic, and biochemical approaches, I demonstrate that the 
channel activity of TRPML1 is necessary for efficient uptake of large particles in macrophages. 
Live imaging revealed that TRPML1 is rapidly recruited to the membrane extensions 
surrounding the particles in the process of phagocytic internalization. Our results are compatible 
with the following working model: large particle binding to macrophages triggers the activation 
of TRPML1 which induces TRPML1-mediated lysosomal Ca
2+
 release and lysosomal exocytosis 
at the site of uptake (Fig. 3.14).  
The involvement of Ca
2+
 in particle uptake and phagosome formation has been unclear 
and rather controversial (Nunes and Demaurex 2010). Early studies demonstrated that the  
activation of IgG Fc receptors during phagocytosis induces a transient increase in intracellular 
Ca
2+
 in neutrophils (Tapper, Furuya et al. 2002; Nunes and Demaurex 2010), but not 
macrophages (Young, Ko et al. 1984; Hishikawa, Cheung et al. 1991). However, recent data 
illustrating the importance of Ca
2+
 induced lysosomal exocytosis in large particle uptake (Braun, 
Fraisier et al. 2004; Braun and Niedergang 2006; Czibener, Sherer et al. 2006) dramatically 
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changed our understanding of the role of Ca
2+
 in this process.  Ca
2+
 is the only known trigger that 
has been identified for lysosomal exocytosis, with SytVII being the primary Ca
2+
 sensor and 
VAMP7 being the SNARE protein required for lysosomal exocytosis. Consistent with the role of 
lysosomal exocytosis in particle uptake, macrophages lacking VAMP7 or SytVII exhibit defects 
in both lysosomal exocytosis and particle uptake, but preferentially under high particle loads. 
This suggests that a small amount of Ca
2+
 release from non-conventional internal stores, that 
might have escaped detection when using conventional Ca
2+
 imaging methods, may play a 
crucial role in macrophage phagocytosis.  
Using our recently established lysosome-specific Ca
2+
 imaging method with lysosome-
targeted genetically encoded Ca
2+
 sensor GCaMP3, which is more sensitive in detecting 
lysosomal Ca
2+
 release than conventional methods, we indeed found that particle binding to 
macrophages also induces Ca
2+
 increase, but exclusively at the site of the particle uptake. 
Furthermore, the present study has extended the earlier observations by demonstrating that 
transient Ca
2+
 release from the lysosomes through TRPML1 is responsible for triggering 
lysosomal exocytosis during the uptake of large particles. Additionally, acidic granules in 
neutrophils (equivalent to lysosomes in macrophages) have been shown to redistribute toward 
the site of particle uptake, suggesting a source of membrane (Stendahl, Krause et al. 1994; 
Theler, Lew et al. 1995). Using time-lapse live imaging, I have demonstrated that lysosomes and 
their resident proteins are also redistributed toward the site of uptake in macrophages. Thus, here 
I showed that lysosomes serve uniquely as sources not only for membranes, but also for Ca
2+
 that 
is required for SytVII activation/recruitment with TRPML1 being the Ca
2+
 channel releasing the 
lysosomal Ca
2+
 (Fig. 3.14). 
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Our results in the present study are consistent with previous reports showing that the 
clearance of late apoptotic neurons is impaired in the Drosophila TRPML (Venkatachalam, Long 
et al. 2008), suggesting that TRPML1 channels play a role in eliminating pathogenic 
extracellular particles. Extracellular accumulation of large particles, such as apoptotic cells, may 
cause brain inflammation and microglia activation, which are common features in most 
neurodegenerative LSDs (Jeyakumar, Dwek et al. 2005). It is possible that defective 
phagocytosis of large particles is a general pathogenic factor for many LSDs, with TRPML1 
channel deregulation in phagocytes being a primary cause. Collectively, I have provided 
innovative links between a lysosomal Ca
2+
 channel, lysosomal exocytosis, large particle uptake, 
and LSDs, and have developed new approaches and chemical reagents to study phagocytosis. 
Given the pivotal role of phagocytosis in clearance of apoptotic cells, our findings may lead to 
new therapeutic approaches for a wide spectrum of neurodegenerative and immune diseases.  
It is not clear how large particle uptake induces the activation machinery for TRPML1 on 
the lysosomes. PI(3,5)P2 is the only known endogenous activator for TRPML1 (Dong, Shen et al. 
2010). However, the biological cues that lead to PI(3,5)P2 production and TRPML1 activation 
are not clear.  Interestingly, phosphatidylinositol 3-kinase (PI3K) activity has been shown to be 
necessary for the uptake of large, but not small particles (Cox, Tseng et al. 1999). PI3K activity 
is mediated through two different isoforms: PI3K type I and III. While type I PI3K has been 
linked to an effect on cytoskeleton rearrangement during large particle uptake (Cox, Tseng et al. 
1999; Hoppe and Swanson 2004), type II PI3K could contribute to large particle uptake via the 
production of PI3P, the precursor of PI(3,5)P2 (Michell, Heath et al. 2006), which in turn is the 

















Figure 3.1 TRPML1 is necessary for optimal phagocytosis of large particles in bone 
marrow macrophages 
 
(A) WT and TRPML1 KO BMMs were exposed to IgG-opsonized red blood cells (IgG-RBCs; 
red colored) at a ratio of 50 RBCs/BMM for time periods indicated (15, 30, 60, and 90 min). 
Non-ingested IgG-RBCs were lysed by briefly (1–2 min) incubating the cells in water at 4°C. 
Samples were then fixed and processed for confocal microscopy. (B) Histograms represent the 
distribution (in percentage) of WT and ML1 KO BMMs containing different numbers of 
ingested RBCs (x-axis) after 90 minutes. (C) Average particle ingestion for WT and TRPML1 
KO BMMs. Ingested IgG-RBCs were quantified for 150–200 BMMs per experiment, by 
experimenters who were blind to the genotype. (D) Particle-size-dependent phagocytosis defect 
of TRPML1 KO BMMs. BMMs were exposed to 2 µm zymosans and 3 or 6 µm IgG-coated 
polystyrene beads for indicated periods of time. Samples were washed extensively and briefly 
trypsinized to dissociate non-ingested beads attached to the cell surface or coverslips. The 
number of ingested particles was determined as described in (B). For all panels, unless otherwise 









































Figure 3.2 The expression level and channel activity of TRPML1 regulate particle Ingestion 
in macrophages. 
 
(A) Micromolar concentrations of ML-SA1 (0.1, 1, and 10 mM; preincubation for 15 min) 
increased particle uptake in WT, but not TRPML1 KO BMMs. BMMs were exposed to IgG-
RBCs in the presence of ML-SA1 for 15 minutes. (B) Transfection of TRPML1-GFP, but not 
TRPML1-KK-GFP (nonconducting pore mutation), rescued the uptake defect in TRPML1 KO 
BMMs. BMMs were exposed to IgG-RBCs for 30 minutes in the presence or absence of the 
small molecule TRPML agonist, ML-SA1 (10 mM). (C) Particle uptake in RAW 264.7, 
TRPML1 O/E, and TRPML1 KD RAW macrophages in the presence or absence of TRPML1 
























Figure 3.3 Phagocytosis of large particles in macrophages is inhibited by TRPML1 
antagonists. 
 
(A & B) ML-SI1 inhibited ML-SA1 or PI(3,5)P2-activated whole-endolysosome currents (C) 
ML-SI1 did not inhibit PI(3,5)P2 induced TPC2 current. (D) ML-SA1 induced rapid increases in 
GCaMP3 fluorescence (measured as change of GCaMP3 fluorescence ΔF over basal 
fluorescence F0; ΔF/F0) under low (<10 nM) external Ca
2+
 in GCaMP3-TRPML1 stable cell 
lines.  Co-application of ML-SI1 abolished the ML-SA1-induced lysosomal Ca
2+
 release.  (E) 
The dose-dependent inhibition of Ca
2+
 increase by ML-SI1 in the micromolar range. (F) ML-SI1 
(10 µM; preincubation for 15 min) inhibited particle ingestion in WT BMMs to a similar level of 
that in TRPML1 KO BMMs. Electrophysiology experiments in sections A, B, and C were 
performed in collaboration with Xiang Wang and Xiaoli Zhang. Ca
2+
 imaging experiment in 















Figure 3.4 Particle binding to macrophages rapidly recruits TRPML1-GFP to the 
phagocytic cups and nascent phagosomes.  
 
(A) Rapid recruitment of TRPML1-GFP to the site of particle ingestion (white arrow) and to 
expanding membrane extensions. Selected frames from time-lapse confocal microscopy of a 
TRPML1-GFP transfected RAW 264.7 macrophage that was exposed to 6 µm IgG-coated 
polystyrene beads. Approximately 1 minute after the attachment of beads to the cell surface, 
TRPML1-GFP was recruited to the membrane extension surrounding the particle (Frame 1 min 
15 s; Movie S1). Note that phagocytosis may have been initiated before the imaging time zero 
due to a technical difficulty in identifying phagocytosing macrophages and capturing 
phagocytosing events, which typically took 5–10 minutes after particles were added to the 
recording chamber. Scale bar represents 5 µm. (B) Particle-size-dependent recruitment of 
TRPML1-GFP to the uptake site.  Time-lapse imaging of a TRPML1-GFP-transfected RAW 
264.7 macrophage that was exposed to both large (6 µm) and small (3 µm) IgG-coated beads 
simultaneously.  Approximately 5 minutes after the attachment of large beads to the cell surface 
(phagocytosis initiation), TRPML1-GFP was present at the membrane extensions surrounding a 
newly formed phagosome (red arrow, frame 5 min 40 sec).  In contrast, for small beads, no 
significant TRPML1-GFP accumulation was seen surrounding the forming phagosome (blue 
arrow, frame 6 min 33 sec).  The center of the particle is indicated with an *.  Scale bar = 10 µm. 
(C) TRPML1-GFP and SytVII-mCherry were simultaneously recruited to nascent phagosomes. 
Selected frames from time-lapse confocal microscopy showed a RAW cell doubly transfected 
with TRPML1-GFP and SytVII-mCherry that was exposed to IgG-RBCs. White box indicates 
the site of particle ingestion; both TRPML1-GFP and Syt VII-mCherry were concurrently 

























Figure 3.5 The recruitment kinetics of different endolysosomal markers to the particle-
containing phagosomes.  
 
RAW macrophage cells were transfected with various molecular endosomal and lysosomal 
markers. Upon particle binding, the recruitment of these markers to phagosomes was monitored 
using live-cell imaging over the course of 40 min. For large particles, TRPML1-mCherry and 
Lamp1-GFP were recruited to the forming phagosomes within 5 min after phagocytosis 
initiation; Rab7-GFP and LysoTracker were observed in the phagosomes 20 minutes after 
phagocytosis initiation; Rab5-GFP appeared on the phagosomes 10 minutes after phagocytosis 
initiation and then disappeared 10 -15 minutes later. For small particles (bottom row), ML1-GFP 
was recruited to the small particle-containing phagosomes 15–20 minutes after phagocytosis 








Figure 3.6 Early recruitment of Lamp1 to nascent phagosomes was defective in TRPML1 
KO BMMs.  
 
BMMs were exposed to IgG-RBCs for 5 min, fixed, and stained with an anti-Lamp1 antibody 
(ID4B). Images represent the morphological criteria used to determine phagosome formation.  
Scale bar = 10 µm. Right panel: percentage of newly-formed phagosomes (5 min after particle 
binding) in WT and TRPML1 KO BMMs that were Lamp1-positive.  Scale bar = 10 µm.  (F). 
Actin polymerization of newly formed phagosomes, shown with phalloidin staining, was 
comparable in WT and TRPML1 KO BMMs. WT and TRPML1 KO BMMs were exposed to 
IgG-RBCs for 5 minutes, fixed, and labeled with phalloidin- Alexa-Fluor633 for 30 minutes.  
Left panel images represent the morphological criteria that were used to determine phagosome 
formation.  The arrows point to RBC-containing phagosomes surrounded by phalloidin-stained 




































Figure 3.7  Whole-phagosome recording of TRPML1 channels in the isolated nascent phagosomes. 
(A) Cartoon illustrations of whole-phagosome recording procedures. Upon RBC uptake (left panel), patch 
electrodes are used to slice open the phagocytosing macrophage within 5 min of particle binding and 
ingestion. After RBC-containing phagosomes are isolated, a patch pipette is used to achieve the whole-
phagosome configuration. (B) An illustration of whole-phagosome configuration.  Cells were transfected 
with Lamp-1-GFP or ML1-GFP and then exposed to IgG-coated beads on ice for 20 minutes; after 
phagocytosis was induced by transferring the cells to 37°C for 5 minutes, the newly formed phagosomes 
were isolated for electrophysiology. (C) ML-SA1- or PI(3,5)P2-activated endogenous whole-phagosome 
TRPML-like currents in RAW 246.7 cells.  (D) Whole-phagosome IML1 in WT, but not ML1 KO BMMs.  
ML-SA1 (25 µM) - activated IML1 was inhibited by ML-SI1 (50 µM) in WT phagosomes (left panel).  No 
ML-SA1- activated IML1 was seen in ML1 KO phagosomes. Electrophysiology experiments were 










(A) BMMs were pre-incubated with the membrane-permeable fast Ca
2+
 chelator BAPTA-AM (1 
µM; 15 min) prior to IgG-RBC exposure for 15 or 90 minutes. After 90 minutes, large particle 
uptake significantly decreases in WT BMMs. Particle uptake was quantified similar as Figure 
3.1. (B) Dose-dependent inhibition of large bead (6 µm) uptake in WT BMMs by low dosage of 
BAPTA-AM, but not slow Ca
2+ 



























Figure 3.9 Particle binding induce TRPML1 mediated lysosomal Ca
2+
 release in 
macrophages 
 
(A) IgG-RBC binding triggered a localized Ca
2+
 increase at the site of uptake, shown with 
selected image frames of a RAW cell doubly-transfected with GCaMP3-TRPML1 and SytVII-
mCherry. Upon IgG-RBC binding, GCaMP3-TRPML1 fluorescence increased rapidly (frame 0 
min 45 sec) near the site of uptake and around the SytVII-mCherry-positive compartments in the 
membrane extension, and then decreased after phagosome formation (frame 6 min 15 sec). 
Right: The time-dependent changes of GCaMP3-TRPML1 fluorescence upon particle binding at 
the site of uptake (white box) and in the cell body (whole-cell region).  White box indicates the 
site of particle uptake.  Scale bar = 10 µm.  (B)  Selected image frames of a RAW cell doubly-
transfected with GCaMP3-TRPML1-KK and SytVII-mCherry. No significant GCaMP3 
fluorescence increase was observed at the site of IgG-RBC uptake and cell body (whole-cell 
region). Right:  Time-dependent change of the GCaMP3-TRPML1-KK fluorescence signal upon 
particle binding.  For all panels, scale bars = 10 µm. For all panels, unless otherwise indicated, 
the data represent the mean ± the standard error of the mean (SEM) from at least three 
































Figure 3.10 TRPML1 is involved in particle uptake induced lysosomal exocytosis.  
(A) Whole-cell TRPML1-like currents in WT BMMs exposed to IgG-RBCs for 10 minutes.  
Dynasore (Dyn, 100 µM) was used to block dynamin-dependent endocytosis in order to facilitate 
the detection of whole-cell TRPML1 current.  No significant whole-cell TRPML1 current was 
detected in TRPML1 KO BMMs (IgG-RBCs for 10 min). (B) Summary of whole-cell TRPML1 
current under different experimental conditions. For all panels, unless otherwise indicated, the 
data represent the mean ± SEM from at least three independent experiments. (C) RBC-ingestion-
induced lysosomal acid phosphatase (AP) release in WT BMMs was reduced by treatment of 
BAPTA-AM (500 nM, pre-incubation for 15 min) or ML-SI1 (10 µM, pre-incubation for 10 
minutes) to the same levels as TRPML1 KO BMMs. Electrophysiology experiments were 











Figure 3.11 TRPML1 mediates particle uptake via the induction of lysosomal exocytosis.  
(A) ML-SA1 (10 µM) failed to increase particle ingestion in TRPML1 O/E RAW cells 
transfected with a SytVII dominant-negative (DN) construct.  Cells were pre-incubated with 
DMSO or ML-SA1 for 15 minutes before they were exposed to IgG-RBCs for 30 minutes.  (B) 
ML-SA1 (10 µM) failed to increase particle ingestion in TRPML1 O/E RAW cells transfected 
with a VAMP7 dominant-negative (VAMP7-DN) construct. (C) A microtubule-disrupting agent 
colchicine (10 µM) inhibited ML-SA1-enhanced particle ingestion in WT BMMs. (D) TeNT 







Figure 3.12 TRPML1 deficiency results in defective clearance of senescent red blood cells 
in the spleen  
 
(A) An increased expression of Lamp1 proteins in TRPML1 KO spleens (B) Lamp1 levels 
increased in the spleen sections of WT and TRPML1 KO mice as released by 
Immunofluorescence staining .  (C) Normalized weight of spleens and kidneys from 4-month-old 
mice (N=5 animals for each).  Inset: Representative images of spleens from 4-month-old WT and 
ML1 KO mice. (D) Accumulation of RBCs in the red (RP) and white (WP) pulps of a TRPML1 
KO spleen revealed by H&E staining. (E) Perl’s (Prussian blue) staining for ferric iron in the 
splenic red pulp (RP) from 4-month-old mice.  Scale bar = 200 µm.  (F) ICP-MS analysis of the 
splenic iron content using digested whole spleens from WT and TRPML1 KO mice.  Data were 
presented as ratios of different ions. For all panels, unless otherwise indicated, the data represent 






































Figure 3.13 Microglia activation and the accumulation of dead cells in the brain of 
TRPML1 KO mice. 
 
(A) Iba1 was up-regulated in the whole-brain lysates of TRPML1 KO mice.  (B) Iba1-positive 
cells were up-regulated in the sections of the brain cortex of TRPML1 KO mice. (C) Propidium 
iodide (PI, 20 µg/ml) -labeled cells in the cerebral cortex and hippocampus of WT and TRPML1 









Large particle (IgG-RBC) binding induces the activation of TRPML1 on the surface of 
lysosomes to induce lysosomal Ca
2+
 release. Juxtaorganellar Ca
2+
 can then trigger lysosome-
plasma membrane fusion, which provides substantial amount of lysosomal membranes for the 
pseudopod extension around IgG-RBCs. As a result, lysosomal membrane proteins, such as 
TRPML1, are inserted into the plasma membrane and become part of the phagocytic cup.  
Pseudopod extension continues until the IgG-RBCs are completely internalized. Phagocytic cups 
are then closed, and nascent phagosomes are formed which contain lysosomal membrane 
proteins. The signaling events that lead to TRPML1 activation in macrophages are not clear, but 














PI(3,5)P2 IS INVOLVED IN PARTICLE UPTAKE IN MACROPHAGES 
 
         Abstract 
Recent evidence indicates that membrane extension and pseudopod formation in 
macrophages depends on the delivery of lysosomal membranes (lysosomal exocytosis) to the site 
of particle uptake through the activation of the lysosomal Ca
2+
 channel TRPML1. Thus, 
lysosomal membrane can compensate for the plasma membrane used during phagosome 
formation. However, the TRPML1 activation mechanism during this process is currently 
unknown. Phosphatidylinositol 3,5-bisphosphate [PI(3,5)P2] is a low-abundance 
phosphoinositide shown to be localized on the endosomes and lysosomes. On the surface of the 
lysosomes, PI(3,5)P2 is the only known endogenous activator for TRPML1 and is suggested to 
be involved in TRPML1 induced lysosomal exocytosis. Here I show that during particle uptake, 
PI(3,5)P2 levels increase on the lysosomes adjacent to the particle ingestion site and at the 
phagocytic cup. Moreover, inhibiting PI(3,5)P2 production through genetic and pharmacological 
approaches blocked particle ingestion in macrophages, indicating that PI(3,5)P2 synthesis on the 







Phosphoinositides (PIs) are signaling molecules involved in a variety of cellular 
trafficking events in different cell types (Di Paolo and De Camilli 2006). In macrophages PIs are  
involved in different signaling events essential for efficient phagocytosis (Gillooly, Simonsen et 
al. 2001; Cosio and Grinstein 2008). During phagocytosis initiation, actin rearrangement is 
required at the site of particle ingestion in order to facilitate pseudopod formation (Allen and 
Aderem 1996). This process has been shown to be dependent on PI(4,5)P2 production, followed 
by the local production of PI(3,4,5)P3, which is required for phagosome sealing (Botelho, Scott 
et al. 2004). The production of both PI(4,5)P2 and PI(3,4,5)P3 are transient and localized at the 
phagosomal cup. Their cellular levels have been shown to decrease after phagosome formation 
(Botelho, Scott et al. 2004). PI3P is known to be important for phagosome maturation and it 
accumulates on phagosomes once phagosomes fuse with the early endosomes. Cells deficient in 
PI3P production have been shown to be defective in phagosomal maturation (Botelho, Scott et al. 
2004).  
Among the PIs, PI(3,5)P2 is the least characterized and its role in phagocytosis remain 
elusive. Recent data have shown that PI(3,5)P2 is localized on the surface of lysosomes and 
activates the lysosomal Ca
2+
 channel TRPML1 (Dong, Shen et al. 2010). As shown in the 
previous chapter, TRPML1 activity is required for large particle uptake in macrophages. 
TRPML1 was shown to regulate large particle uptake by mediating lysosomal exocytosis and 
therefore regulating the delivery of lysosomal membrane to the site of particle uptake in order to 
provide excess membrane for phagosome formation (Chapter III). Here, I hypothesized that 
TRPML1 activation during particle uptake is regulated through the production of PI(3,5)P2 on 
the lysosomes adjacent to the site of particle uptake. By using a recently established fluorescent 
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tagged PI(3,5)P2 probe developed in our lab, I was able to characterize the dynamics of PI(3,5)P2 
during particle ingestion and reveal that, during particle ingestion PI(3,5)P2 is synthesized on the 




Fluorescence and time-lapse imaging Live imaging of RBC uptake by BMMs was performed 
on a heated stage using a Spinning Disk confocal imaging system consisting of an Olympus 
IX81 inverted microscope, a 100X Oil objective NA 1.49 (Olympus, UAPON100XOTIRF), a 
CSU-X1 scanner (Yokogawa), an iXon EM-CCD camera (Andor), and MetaMorph Advanced 
Imaging acquisition software v.7.7.8.0 (Molecular Devices).  The PI(3,5)P2 probe was generated 
with the tandem repeats of the TRPML1 N-terminal segment (residues 1–68) fused with a GFP 
tag (Li, Wang et al. 2013).  All images were taken with the 100X objective of a Leica (TCS SP5) 
confocal microscope.   
HPLC measurement of phosphoinositide levels.   Raw macrophage cell lines were grown in 6 
well plates to 20-30% confluence.  Cells were then rinsed twice with PBS and incubated for 48 
hours with the inositol labeling medium, contained inositol-free DMEM, 10 μCi/mL of myo-[2-
3
H] 
inositol (GE Healthcare), 10% (vol/vol) dialyzed FBS, 20 mM Hepes, 5 μg/mL transferrin, and 5 
μg/mL insulin (Zolov, Bridges et al. 2012).  Afterwards, a solution (pre-warmed to 37°C) of IgG-
coated 6 µM polystyrene beads was prepared in a 1:50 ratio (macrophage:beads).  After RAW cells 
were rinsed with PBS once, 4 ml of beads were added to each well.  The plates were centrifuged 
briefly for 1 minute at 3,000 RPM and then placed in the 37°C incubator for 1, 2, 5, and 10 minutes.  
After each time point, the un-ingested beads were removed and RAW cells were  treated with 500 
µl of ice-cold 4.5% (vol/vol) perchloric acid for 15 minutes at room temperature. The plates were 
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rotated gently every 2 minutes in order to prevent cells from drying.  RAW cells were then scraped 
off, spun at 12,000 × g for 10 minutes at 4 °C, and then processed for HPLC measurement.  The 





PI(3,5)P2 is up-regulated at the site of particle uptake 
PI(3,5)P2 is the only known endogenous activator of TRPML1 (Dong, Shen et al. 2010) 
and TRPML1 activation has been shown to be required for efficient large particle uptake in 
macrophages (Chapter III). Thus, I hypothesized that PI(3,5)P2 levels are elevated during particle 
ingestion in order to mediate the activation of TRPML1. To directly test the possibility that an 
elevation of PI(3,5)P2 is locally triggered by large particle binding, I used the newly generated 
PI(3,5)P2-specific probe, ML1-2N-GFP, made by the fusion of GFP to the phosphoinositide-
binding domain of TRPML1 (Li, Wang et al. 2013), to detect dynamics of PI(3,5)P2.  Strikingly, 
ML1-2N-GFP was rapidly recruited to the forming phagosomes (Fig. 4.1A) in RAW cells that 
were doubly transfected with ML1-2N-GFP and SytVII-mCherry. A transient and localized 
increase in ML1-2N-GFP fluorescent intensity was observed preferentially at the uptake sites of 
SytVII-mCherry-positive lysosomes within three minutes of particle binding (Fig. 4.1A, frame 2 
min and 54 sec).  In contrast, no increase in GFP fluorescence was observed in cells transfected 
with ML1-7Q-2N-GFP (a PI(3,5)P2 unbinding control probe) (Fig. 4.1B), indicating the 
specificity of the probe.  
We also measured the radio-labeled phosphoinositides using high-performance liquid 
chromatography (HPLC).  We found that PI(3,5)P2 levels increased significantly during the first 
5 minutes of phagocytosis upon particle binding, which corresponds to the time necessary for 
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phagosome formation (Fig. 4.2). Interestingly, PI3P levels also increase with similar kinetics to 
PI(3,5)P2 (Fig. 4.2). This wasn’t unexpected because on the lysosomal compartments PI(3,5)P2 is 
generated from PI3P on the endosomes, so it make sense for PI3P levels to increase with similar 
kinetics as PI(3,5)P2 since it’s the precursor for PI(3,5)P2 production (Zolov, Bridges et al. 
2012). The levels of other PIs, such as PI4P, PI5P, and PI(4,5)P2, did not change during the same 
time point suggesting that localized PI(3,5)P2 generation may be one of the initial steps during 
large particle ingestion (Fig. 4.2). 
 
PI(3,5)P2 activity is required for efficient large particle uptake in macrophages 
 PI(3,5)P2 is generated from PI3P by a protein complex that contains PIKfyve, a PI kinase 
that is localized on the late endosomes and lysosomes (Jefferies, Cooke et al. 2008).  The activity 
of PIKfyve is dependent on the FIG4 protein in the complex (Lenk, Ferguson et al. 2011). Thus, 
macrophages isolated from FIG4 KO mice are predicted to have a reduced PI(3,5)P2 level 
compared with WT cells (Chow, Zhang et al. 2007).  FIG4 KO BMMs contained enlarged 
Lamp1-positive compartments (Fig. 4.3A), as seen in other cells types from FIG4 KO mice 
(Chow, Zhang et al. 2007). Similar to TRPML1 KO BMMs, FIG4 KO BMMs were also 
defective in IgG-RBC uptake (Fig. 4.3B) and IgG-RBC-induced lysosomal AP release (Fig. 
4.3C), illustrating that cells deficient in PI(3,5)P2 exhibit similar characteristics as TRPML1 
deficient macrophages. Additionally, I evaluated large and small particle uptake in WT 
macrophages after exposing them to PIKfyve specific inhibitor YM201636 (Jefferies, Cooke et 
al. 2008). Interestingly, large (6 µm), but not small (3 µm) bead uptake, was defective in WT 
BMMs treated with YM201636 similar to macrophages isolated from FIG KO mice (Fig. 4.4A-
98 
 
C). Collectively, these data suggest that PI(3,5)P2 participates in large particle uptake and 
lysosomal exocytosis, a phenotype similar to TRPML1 KO macrophages.  
 
PI(3,5)P2 levels increase during particle uptake prior to phagosome maturation  
PI(3,5)P2 has been shown to exist on the surface of lysosomes (Li, Wang et al. 2013). 
Lysosomes are traditionally believed to be delivered to phagosomes through the phagosomal 
maturation process in order to facilitate the degradation of the ingested particle (Aderem and 
Underhill 1999; Flannagan, Jaumouille et al. 2012). However, in previous chapters I illustrated 
that lysosomes get delivered to the site of particle ingestion via lysosomal exocytosis in order to 
provide excess membrane for phagosome formation. Our data indicated that PI(3,5)P2 levels are 
increased at the site of particle uptake (Fig. 4.1), so I sought to determine at what stage of 
phagosome formation P(3,5)P2 levels are increased.  
I analyzed the kinetics of two other PIs known to accumulate on the surface of 
phagosomes at different stages. PI3P accumulates on phagosomes after formation and before the 
final delivery to lysosomes, this was detected using the 2X-FYVE-GFP probe. On the other 
hand, PI(3,4,5)P3 has been shown to accumulate to the forming phagosomes before closure and  
was detected using the AKT-PH-GFP probe (Yeung, Ozdamar et al. 2006). Consistent with this, 
the AKT-PH-GFP probe accumulated rapidly on forming phagosomes, but quickly disappeared 
upon closing of phagocytic cups within several minutes (Fig. 4.5A). The time course of 
PI(3,4,5)P3 production matches phagosome formation and closure as shown previously(Yeung, 
Ozdamar et al. 2006).  In contrast, the PI3P probe accumulated on the early phagosomes 
approximately 10 minutes after phagosome initiation (Fig. 4.5B), which was similar to Rab5 
recruitment to early phagosomes (Fig. 3.5).  Note that PI3P increase occurred after SytVII 
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recruitment (Fig. 4.5B). Because PI(3,5)P2 accumulates at the phagocytic site with a time course 
similar to PI(3,4,5)P3 and prior to PI3P, it is very likely that PI(3,5)P2 increase occurs during 
phagosome formation.   
      Discussion 
 
PIs have been extensively studied in macrophages and in the course of phagocytosis 
(Gillooly, Simonsen et al. 2001; Yeung, Ozdamar et al. 2006; Cosio and Grinstein 2008). 
However, the localization and dynamics of PI(3,5)P2 in macrophages remained largely unknown, 
mainly due to the lack of a direct method to visualize this low-abundance phosphoinositide. By 
using a recently established fluorescent tagged PI(3,5)P2 probe, I illustrated that PI(3,5)P2 gets 
synthesized on the lysosomes adjacent to the site of particle uptake (Fig. 4.6) and its production 
is required for lysosomal exocytosis and large particle uptake in macrophages. These phenotypes 
are reminiscent of TRPML1 KO macrophages. PI(3,5)P2 is the only known endogenous activator 
for TRPML1 (Dong, Shen et al. 2010). Therefore, it is possible that PI(3,5)P2 regulates large 
particle uptake through the activation of TRPML1 in macrophages.  
What differentiates the uptake of large vs. small particles is not clear. A small increase in 
the diameter of particles may result in a much larger demand for membranes, receptors, signaling 
molecules, and cytoskeleton machinery. It is known that the uptake of large (> 4.5 µm) IgG-
coated particles depends on phosphatidylinositol 3-kinase (PI3K) activity, whereas the uptake of 
smaller (< 3 µm) particles does not require PI3K activity (Cox, Tseng et al. 1999). For example, 
wortmannin and LY294002, two non-specific type I & II PI3K inhibitors, preferentially inhibit 
the uptake of large particles(Cox, Tseng et al. 1999; Hoppe and Swanson 2004).  While type I 
PI3K has been linked to an effect on cytoskeleton rearrangement during large particle uptake 
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(Cox, Tseng et al. 1999; Hoppe and Swanson 2004), type II PI3K could contribute to large 
particle uptake via the production of PI3P, the precursor of PI(3,5)P2, which in turn acts as the 



















Figure 4.1 PI(3,5)P2 levels are elevated adjacent to the site of particle uptake. 
(A) Upon particle binding, ML1-2N-GFP and SytVII-mCherry accumulated at the site of uptake 
within minutes.  Note that phagocytosis initiation may have occurred before the imaging time 
zero due to a technical difficulty in identifying macrophages undergoing phagocytosis. Scale bar 










Figure 4.2  HPLC analysis of the levels of different PIs during phagosome formation.   
Myo-[2-3H] inositol-labeled RAW cells were exposed to IgG-coated beads (6 µm) in a 1:50 ratio 
(macrophage:beads) and then centrifuged at 4°C to synchronize the phagocytosis event. After 
centrifugation, cells were placed at 37°C for 0, 1, 2, 5, and 10 minutes.  After each time point, 
cells were harvested and prepared for HPLC analysis.  Data is from three independent 
experiments. HPLC experiments were performed in collaboration with Sergey Zolov and Lois 














Figure 4.3 FIG4 KO macrophages are defective in large particles.   
(A) Enlargement of Lamp1-positive compartments in FIG4 KO BMMs.  Scale bar = 5 µm. (B) 
FIG4 KO macrophages were defective in IgG-RBC ingestion.  WT and FIG4 KO BMMs were 
exposed to IgG-RBCs for the time periods indicated. (C) IgG-RBC (30 min)-induced lysosomal 










Figure 4.4 PIKfyve activity is required for the efficient uptake of large particles.  
(A) DMSO (control) or YM0201636 (1 µM for 1 hour) treated macrophages were exposed to 
IgG-opsonized small (3 µm) or large (6 µm) beads for 30 minutes. Samples were then fixed and 
processed for confocal microscopy. YM0201636 treated cells exhibited large vacuoles (B) 








Figure 4.5 PI(3,5)P2 up-regulation occurs prior to phagosomal maturation.  
(A) Distinct recruitment kinetics of AKT-PH-GFP (PI(3,4,5)P3/PI(3,4)P2 probe) and 2X-FYVE-
GFP (PI3P probe) to forming phagosomes. AKT-PH-GFP probe is up-regulated during the 
formation of new phagosome, while 2X-FYVE-GFP gets synthesized on the phagosomes 10 
minutes after formation. Scale bars = 10 µm. (B) While SytVII-mCherry appeared on the 
forming phagosomes within 3-5 minutes of phagocytosis initiation, 2X-FYVE-GFP (PI3P probe) 
appeared on phagosomal membranes several minutes later (9 min 40 sec).  The center of the 





























Figure 4.6 phosphoinositides dynamics during phagocytosis.  
The changes in the relative abundance of each PI are illustrated in the figure. PI(3,5)P2 is up-
regulated on the lysosomes adjacent to the site of particle uptake and regulates the activity of 
TRPML1 (not shown), which is required for lysosomal fusion with the plasma membrane in 
order to provide excess membrane for particle ingestion. PI(4,5)P2 is synthesized on the 
phagocytic cup and is involved in actin polymerization. During particle ingestion and pseudopod 
extensions, PI(4,5)P2 mainly gets converted to PI(3,4,5)P3, which is required for phagocytic cup 
closure and the final step of particle ingestion. Once the phagosomes are formed they go through 
the phagosomal maturation pathway where PI3P gets synthesized on the surface of phagosomes 









 CHAPTER V 
  
TRPML1 MEDIATES THE DEGRADATION OF INTRACELLUALR 
PATHOGENS IN MACROPHAGES 
 
Abstract  
Inhibiting phagosome-lysosome fusion is crucial for intracellular survival and replication 
of many intracellular pathogens within the macrophages. Here, I found that the lysosomal cation 
channel Mucolipin TRP channels 1 (TRPML1) limits the intracellular replication of photogenic 
bacteria. I observed that bacteria elimination in macrophages is inhibited by synthetic TRPML1 
blockers and is defective in macrophages isolated from TRPML1 knockout mice. Using time-
lapse confocal imaging I observed that TRPML1 facilitates the fusion of phagosomes containing 
bacteria with lysosomes in a calcium dependent manner. In addition, TRPML1 was also shown 
to deplete lysosomes from the iron shown to be necessary for bacteria growth within the 
lysosomal compartments. Therefore, TRPML1 potentially has a dual role in macrophage 
bactericidal activity; mediating the lysosomal fusion and depleting lysosomes from the nutrients 









Salmonella is an intracellular pathogen responsible for a variety of diseases in humans 
such as typhoid fever, paratyphoid fever, and gastroenteritis (Haraga, Ohlson et al. 2008). 
Macrophages are one of the main immune cells responsible for ingestion and elimination of 
Salmonella (Haraga, Ohlson et al. 2008). However, Salmonella have developed a set of 
mechanisms to alter and hijack the trafficking and signaling pathways of macrophages for their 
own benefit and survival (Radtke and O'Riordan 2006). Within macrophages, Salmonella 
replicate in membrane-bound vacuoles referred to as Salmonella-containing vacuoles (SCVs) 
(Haraga, Ohlson et al. 2008; Figueira and Holden 2012). Once formed, SCVs interact with 
endoctytic compartments and exhibit characteristics closely resembling the late endosomes, 
however, they avoid fusion with lysosomes by targeting evolutionary conserved proteins 
involved in lysosomal fusion (Drecktrah, Knodler et al. 2007). In addition, once SCVs survive 
lysosomal fusion they utilize nutrients they receive from endocytosis, such as iron, in order to 
replicate within the host cells (Puschmann and Ganzoni 1977).   
TRPML1 is a non-selective cation channel on the surface of the late 





from the luminal side of lysosomes into the cytoplasm (Dong, Cheng et al. 2008; Cheng, Shen et 
al. 2010; Dong, Shen et al. 2010). Human mutations of TRPML1 cause Mucolipidosis type IV 
(MLIV), a childhood neurodegenerative disorder with lysosomal trafficking defects at the 
cellular level (Amir, Zlotogora et al. 1987; Bach 2001; Altarescu, Sun et al. 2002). Since late 
endosome-lysosome fusion has been suggested to be regulated by Ca
2+
 release from the 
compartments themselves (Luzio, Rous et al. 2000; Luzio, Bright et al. 2007), it has been 
suggested that TRPML1 regulates the late endosome/lysosomes fusion. In correlation with this, 
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TRPML1 activity has been shown to be regulated by the lysosomal phosphoinositide PI(3,5)P2, 
which is required for late endosome/lysosome trafficking events (Jefferies, Cooke et al. 2008). 
Interestingly, macrophages deficient in PI(3,5)P2 have been shown to be defective in restricting 
intracellular survival of Salmonella (Kerr, Wang et al. 2010) suggesting that PI(3,5)P2 could 
possibly influence the intracellular growth of Salmonella in macrophages through TRPML1.  In 
addition to its role in membrane trafficking, TRPML1 KO fibroblasts have also been known to 
accumulate Fe
2+
 in their lysosomes (Dong, Cheng et al. 2008). Iron is a critical nutritional 
element and essential for Salmonella metabolism (Puschmann and Ganzoni 1977). Collectively 
these data suggest that TRPML1 could potentially play a double role against Salmonella growth; 
it can promote lysosome fusion and deplete lysosomes from the iron necessary for their survival. 
Here I provide evidence that TRPML1 is involved in the efficient elimination of intracellular 
Salmonella in macrophages.  
 
Methods 
Macrophage cell culture.  Murine bone marrow derived macrophages (BMMs) were prepared 
and cultured as described previously (Link, Park et al. 2010).  Briefly, bone marrow cells from 
mouse femurs and tibias were harvested and cultured in macrophage differentiation medium 
(RPMI-1640 medium with 10% fetal bovine serum (FBS) and 100 unit/ml recombinant colony 
stimulating factor (PeproTech, Rocky Hill, NJ).  After 7 days in culture at 37 °C with 5% CO2, 
the adherent cells (> 95% are expected to be macrophages) were harvested for assays. RAW 
264.7, RAW cells stably expressing TRPML1 (ML1 overexpression or O/E), and RAW cells 
stably expressing TRPML1-specific RNAi (ML1 knockdown or KD) (Thompson, Schaheen et 
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al. 2007) were kindly provided by Dr. Hanna Fares (University of Arizona) and cultured in 
DMEM/F12 media supplemented with 10% FBS at 37°C with 5% CO2. 
Salmonella infection. Salmonella infection was performed as shown before (Roy, Liston et al. 
2004). Briefly, BMMs from WT and TRPML1 KO mice were seeded at 1 X 10
6
/well on a 6 well 
tissue culture plate 24 hours prior to experiments. A 1:30 dilution of overnight Salmonella 
culture was grown in LB broth for 3 hours at 37°C while shaking at 300 rpm (a condition that 
minimizes induction of cytotoxicity in macrophages). Bacteria re-suspended in tissue culture 
medium was added to cells at a multiplicity of infection (MOI) of 10, dishes were centrifuged 
(50g, 2 min) and incubated at 37°C for 45-60 minutes. Then they were washed, and incubated 
with fresh medium containing gentamicin at 100 μg/ml for the desired infection period. For 
determining colony forming units (CFU), infected monolayers were washed and lysed in PBS 
containing 0.1% Triton X-100. The lysates were serially diluted and spread on LB agar plates 
containing the appropriate antibiotics, and incubated at 37°C. The number of colonies was 
counted the next day.  
 
Antibodies and fluorescence microscopy. After bacterial infection, cells were washed, fixed 
with 4% paraformaldehyde in PBS at 4°C for 1 hour, permeabilized in PBS 1% BSA 0.1% and 
0.3% Triton X, and incubated with Lamp-1 primary(1D4B) and secondary antibodies. For co-
localization of bacteria with dextran-containing lysosomes, cells were incubated with 0.5 mg/ml 
lysinefixable dextran-Texas red (10 kDa, Molecular Probes) for 1hour and chased for 3 hour in 
fresh media, prior to infection. The number of intracellular bacteria associated with >200 cells 
(determined by antibody staining or GFP expression in the presence of extracellular gentamicin) 
was determined visually in triplicate. Phagolysosome fusion was quantified by examining all 
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phagosomes in approximately 5 randomly acquired optical images for each experimental 
condition.  TUNEL assays for in situ detection of apoptotic macrophages were performed 
according to the manufacturer’s instructions (Roche).  
 
Lysosome isolation by subcellular fractionation. Lysosomes were isolated as described 
previously with modifications (Kim, Soyombo et al. 2009). Briefly, cell lysates were obtained by 
Dounce homogenization in a homogenizing buffer (HM buffer; 0.25 M sucrose, 1 mM EDTA, 
10 mM HEPES, and pH 7.0), and then centrifuged at 1900 g (4, 200 rpm) at 4°C for 10 min to 
remove the nuclei and intact cells. Post-nuclear supernatants then underwent ultracentrifugation 
through a Percoll density gradient using a Beckman L8-70 ultracentrifuge. An ultracentrifuge 
tube was layered with 2.5 M sucrose and 18% Percoll in HM buffer. Centrifugation speed was 
67,200 g at 4°C for 1 hour using a Beckman Coulter 70.1 Ti Rotor. Samples were fractionated 
into light, medium, and heavy membrane fractions. Heavy membrane fractions contained 
concentrated bands of cellular organelles and were further layered over a discontinuous iodixonal 
gradient. The iodixonal gradient was generated by mixing iodixonal in the HM buffer with 2.5 M 
glucose (in v/v; 27%, 22.5%, 19%, 16%, 12%, and 8%); the osmolarity of all solutions was ~ 
300 mOsm. After centrifugation at 4°C for 2.5 hours, the sample was divided into 10 fractions 
(0.5 ml each) for biochemical and atomic absorption analyses. Note that the ionic composition of 
the lysosome was largely maintained due to the low rate of ion transport across the lysosomal 
membrane at 4°C. Antibodies used for western blots: anti-Lamp1 (Iowa Hybridoma bank), 
1:5000 dilution; anti-Annexin V (Abcam), 1:2000 dilution; anti-GM130 (Abcam), 1:2000 
dilution; anti-EEA1 (Santa Cruz Biotechnology), 1:500 dilution; anti-Complex II (Abcam), 




Inductively Coupled Plasma Mass Spectrometry (ICP-MS) 
Lysosomal fractions were prepared for atomic absorption by diluting the samples at a 1:1 ratio 
with concentrated nitric acid. After digestion (10min, 60ºC), the ionic composition was measured 
using a Thermo Scientific Finnigan Element inductively coupled with a plasma-high resolution 




Macrophages lacking TRPML1 are defective in restricting intracellular Salmonella growth 
In order to determine whether TRPML1 plays a role in Salmonella infection, WT and 
TRPML1 KO macrophages were infected with Salmonella WT strain SL1344 expressing GFP 
(GFP-SL1344) as described in the methods section for different time periods (Fig. 5.1A&B). 
The initial amount of ingested Salmonella was comparable between WT and TRPML1 KO 
macrophages (time 0; Fig. 5.1A&B). However, in TRPML1 KO macrophages, bacterial growth 
started shortly after entry, as the intracellular growth of Salmonella was significantly enhanced in 
TRPML1 KO macrophages after about 2 hours of infection and continued to increase vigorously 
with time (Fig. 5.1B). In contrast, Salmonella growth not only did not increase in WT 
macrophages, but instead decreased initially for the first 10 hours and increased modestly after 
24 hours (Fig. 5.1B), most likely due to the bactericidal activity of WT macrophages. 
Interestingly, similar results were also obtained using different concentrations of TRPML1 
specific inhibitor ML-SI1 (Fig. 5.1A&B and Fig 5.2A) and PIKfyve specific inhibitor 
YM201636 (Jefferies, Cooke et al. 2008) (Fig. 5.1B), confirming the results obtained previously 
showing that PIKfyve inhibition enhances the intracellular growth of Salmonella in macrophages 
(Kerr, Wang et al. 2010). Similar results were also obtained in macrophage cell lines with altered 
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expression levels of TRPML1 (Chapter II, Fig. 2.4) where Salmonella growth enhanced 
significantly in macrophage cell lines with lower expression levels of TRPML1 (Fig. 5.2B). This 
increase in intracellular growth of Salmonella in TRPML1 KO macrophages was not related to 
Salmonella-induced macrophage cytotoxicity. Under the growth conditions used, Salmonella 
induced similar low levels of programmed cell death on both WT and TRPML1 KO 
macrophages and did not cause differential cell loss between 2 and 6 hours after infection, as 
shown by TUNEL staining (Fig. 5.2C). Collectively, these data suggest that TRPML1 is 
involved in restricting the intracellular growth of Salmonella in macrophages.  
 
TRPML1 influence the fusion of Salmonella with lysosomes in a Ca
2+ 
dependent manner. 
The knockdown of TRPML1 using shRNA against the TRPML1 gene in macrophage cell 
lines and fibroblasts isolated from MLIV patients demonstrated a delay in lysosomal delivery 
and subsequent  delay in the degradation of endocytosed proteins, such as BSA and platelet-
derived growth factor receptors (PDGF-R) (Thompson, Schaheen et al. 2007; Vergarajauregui, 
Oberdick et al. 2008). Considering these data, I hypothesized that TRPML1 could potentially be 
involved in the delivery of SCVs to the lysosomes by facilitating the release of lysosomal Ca
2+
 
and regulating lysosomal fusion (Luzio, Rous et al. 2000; Luzio, Bright et al. 2007); therefore, 
lack of TRPML1 will enhance Salmonella survival in macrophages.  
I investigated whether the fusion of lysosomes with phagosomes containing Salmonella is 
defective in TRPML1 KO macrophages. As mentioned before, Salmonella reside in 
compartments exhibiting late endosome characteristics, but they avoid fusion and degradation by 
lysosomes (Drecktrah, Knodler et al. 2007). Late endosome/lysosome membrane protein, Lamp-
1, was used to label late endosomes/lysosomes, while fluorescent conjugated dextran was used to 
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label lysosomes (Fig. 5.3A&B). Macrophages were infected with Salmonella for 6 hours and the 
extent to which Salmonella-containing phagosomes colocalized with Lamp-1 or dextran 
preloaded into lysosomes was quantified in WT and TRPML1 KO macrophages from images 
obtained from confocal microscopy (Fig. 5.3A&B). The percentage of Salmonella-containing 
phagosomes positive for Lamp-1 and dextran was comparable in WT cells. However, TRPML1 
KO macrophages or macrophages treated with ML-SI1 contained a significantly higher 
percentage of Salmonella-containing phagosomes positive for Lamp-1 compared to dextran, 
indicating the late endosome/lysosomes fusion was defective (Fig. 5.3A&B). Similar results 
were also obtained by using live confocal microscopy where lysosomal fusion was blocked using 
ML-SI1 and YM 201636 compound (Fig. 5.4). Interestingly, treating cells with the fast Ca
2+
 
chelator BAPTA-AM also resulted in similar results (Fig. 5.3A&B) suggesting that TRPML1 
potentially regulates the fusion of Salmonella-containing phagosomes with lysosomes by 
providing the Ca
2+
 required for lysosomal fusion.  
In order to further investigate this possibility, the intracellular survival of Salmonella was 
evaluated after exposing the cells to different concentrations of the fast and slow Ca
2+
 chelators. 
The survival rate of Salmonella was significantly increased in WT macrophages treated with 
BAPTA-AM, almost to the same level of TRPML1 KO macrophages, in a dose dependent 
manner, while the slow Ca
2+
 chelator EGTA-AM had a minor effect (Fig. 5.5). BAPTA binds to 
Ca
2+
 approximately 100 times faster than EGTA does, thus EGTA is more likely not able to 
chelate Ca
2+
 close to the site of Ca
2+
 release (explained in detail in Chapter I) (Pryor, Mullock et 
al. 2000; Luzio, Bright et al. 2007). Collectively, these data illustrated that TRPML1 potentially 
provides the Ca
2+
 required for membrane fusion between the SCVs and lysosomes. These data 





phagosome-lysosome fusion and pathogen elimination in macrophages (Nunes and Demaurex 
2010). 
  
Lack of TRPML1 leads to accumulation of intra-lysosomal iron and increase in Salmonella 
growth  
As shown earlier in TRPML1 KO macrophages, bacterial growth started shortly after 
entry, as the intracellular growth of Salmonella was significantly enhanced in TRPML1 KO 
macrophages after about 2 hours of infection, and continued to increase with time (Fig. 5.1). 
This data suggested that, in TRPML1 KO macrophages, not only are Salmonella able to survive 
lysosomal degradation, but they are also able to replicate dynamically, meaning they most likely 
have access to nutrients they require for metabolism.  Lysosomal iron has been shown to be 
crucial for microbial growth and replication within macrophages (Schaible and Kaufmann 2004), 
so it is no surprise that iron accumulation in endosomal/lysosomal compartments is associated 
with an increased susceptibility to bacterial infections (Wanachiwanawin 2000). Meanwhile, the 
depletion of lysosomal iron was shown to increase natural resistance against intracellular 
pathogen (Puschmann and Ganzoni 1977). Nramp-1 is a known iron efflux transporter on the 
surface of the lysosomes shown to deplete lysosomal iron upon infection in order to prevent 
bacteria replication within the lysosomes (Gunshin, Mackenzie et al. 1997; Cuellar-Mata, Jabado 
et al. 2002). Recent studies indicate that TRPML1 is able to conduct iron from the luminal side 
of the lysosomes into the cytoplasm (Dong, Cheng et al. 2008), Hence, we hypothesized in 
addition to modulating lysosome-phagosome fusion, TRPML1 can potentially play a similar role 
as Nramp-1 and restrict intracellular Salmonella growth by depleting lysosomal iron.  
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To explore this possibility, I first evaluated the iron content of lysosomes in TRPML1 
KO macrophages. To directly measure the ionic composition of the lysosome lumen, we 
enriched the lysosome fraction of HEK293T cells using density-gradient centrifugation (Fig. 
5.6A). The cell homogenate (designated Fraction A in Fig. 5.6A) was subjected to two rounds of 
density-gradient centrifugation steps, which progressively separated lysosomes from other 
organelles. Centrifugation of the homogenate at 4200 rpm eliminated unbroken cells and the 
damaged membranes. The supernatant contained significant amounts of most of the cellular 
organelles (Fig. 5.6B; fraction C). Fraction C was then subjected to centrifugation through a 
discontinuous percoll gradient and yielded three main fractions designated light, medium, and 
heavy membrane fractions (Fig. 5.6A). The heavy membrane fractions contained the lysosomal 
organelles (Fig. 5.6B), but it was still contaminated with mitochondria (Fig. 5.6B; fractions F 
and G). In order to further purify lysosomes, we combined fractions F and G and subjected them 
to an additional centrifugation step through continuous iodixanol gradient (Fig. 5.6C). We were 
able to obtain pure lysosomes in lower percentage fractions of the iodixanol gradient (Fig. 5.6C). 
After isolating lysosomes, they were subjected to inductively coupled plasma mass spectrometry 
(ICP-MS) analysis to analyze the ionic composition of the lysosomes. All centrifugation steps 
were performed at 4°C (1 hour in the Percoll density gradient and 2.5 hour in the iodixanol 
gradient). At this temperature, the rate of ion transport across the lysosomal membrane is 
expected to be extremely low. In addition, the sucrose-based homogenization buffer contains few 
ions. Thus, lysosomal ion transporters/exchangers are not likely to be operative. Hence, we 
presume that the lysosomal ion composition is largely maintained during the isolation procedure. 
Although the absolute concentrations of ions could not be accurately measured due to the lack of 
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information about lysosome volume, this approach allowed us to determine the relative 
abundance/ratios of the total but not free ions in the lumen.  
By using this approach, we were able to isolate lysosomes from macrophages and 
evaluate their ionic compositions. The basal level of total iron levels was comparable in the 
lysosomes of WT and TRPML1 KO macrophages (Fig. 5.7A). However, after we treated the 
culture macrophages with iron conjugated dextran overnight (under this condition, endocytosed 
iron is expected to be localized exclusively in the lysosomes), we observed an accumulation of 
iron in TRPML1 KO, but not WT macrophages (Fig. 5.7A). The total levels of magnesium 
remain unchanged, indicating that lysosomal iron increases specifically. Additionally, the 
accumulation of lysosomal iron  in cultured macrophages was confirmed by using sulphide-silver 
method (SSM) staining. Significantly more lysosomal iron staining was seen in TRPML1 KO 
macrophages compared to WT cells (Fig. 5.7B) indicating that iron accumulates within the 
lysosomes of TRPML1 KO macrophages. Interestingly, Salmonella growth was elevated in the 
TRPML1KO macrophages after treating the cells with iron dextran overnight (Fig. 5.7C) 
indicating that lack of TRPML1 can enhance Salmonella metabolism by providing excess iron 
essential for Salmonella replication.  
 
Discussion  
Salmonella can get inside host cells through several different routes such as phagocytosis 
or macropinocytosis, but no matter how they get into the cell they manipulate the encompassing 
vacuoles in order to generate a replicative niche that supports its survival and growth (Weber, 
Ragaz et al. 2009). The invasion and intracellular replication of Salmonella is a carefully 
choreographed interplay between the host cell’s molecular machinery and secreted effectors of 
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the pathogen which hijacks the endogenous host cell machinery for their own benefits (Haraga, 
Ohlson et al. 2008). One of the key events required for Salmonella survival within the host cell is 
lysosomal fusion avoidance (Drecktrah, Knodler et al. 2007). Here, by using both genetic and 
pharmacological manipulations, I showed that cells lacking the lysosomal Ca
2+
 channel 
TRPML1 are defective in restricting intracellular growth of Salmonella in macrophages. 
TRPML1 is a lysosomal Ca
2+
 channel shown to be involved in mediating membrane fusion 
events in different cell types late in the endocytic/excotytic pathways (Cheng, Shen et al. 2010). 
By using confocal microscopy, I observed that in TRPML1 deficient macrophages, Salmonella 
avoid fusion with lysosomes and they remain in late endosomal compartments. Therefore, they 
are able to avoid lysosomal degradation and survive within the cells. Additionally, I showed 
there is an accumulation of iron in the lumen of the lysosomes in TRPML1 KO macrophages, 
which could provide additional nutrition required for Salmonella growth (Puschmann and 
Ganzoni 1977; Cuellar-Mata, Jabado et al. 2002; Jabado, Cuellar-Mata et al. 2003). Therefore, 
here for the first time, I have potenitally identified a cation channel responsible for two 
fundamental process involved in host cell bactericidal activity; promoting lysosomal fusion and 
depleting lysosomes from nutrients, such as iron, required for Salmonella growth.   
 Although I have suggested the mechanisms of how TRPML1 restricts intracellular 
growth of Salmonella in vitro, this remains to be tested in vivo on animal models. Also, it needs 
to be discovered if Salmonella effectors directly interact and inhibit TRPML1 in the host cells. 
Moreover, how intracellular iron regulates Salmonella replication and its relation to TRPML1 
needs further investigation. Exposing WT macrophages to BAPTA-AM was sufficient to induce 
Salmonella replication to the same levels of TRPML1 KO macrophages (Fig. 5.5), illustrating 





 release. However, the intracellular survival of Salmonella was more evident after 
the addition of exogenous iron (Fig. 5.7). Nevertheless, it needs to be noted that exogenous iron 
could potentially alter lysosomal ionic composition and therefore, Salmonella growth observed 
in these experiments could be due to secondary effects, such as altering lysosomal Ca
2+
 
concentration, independent from TRPML1. So, the interplay between Ca
2+
 and iron needs to be 
separated and investigated more in detailed.  
Interestingly, macrophages lacking TRPML1 endogenous activator PI(3,5)P2 also exhibit 
a similar phenotype as TRPML1 KO macrophages, so it is possible that TRPML1 is a major 
target for Salmonella effectors in order to promote the bacteria growth within the macrophages. 
With the development of antibiotic resistant bacteria strains, new strategies to combat infection 
must be devised. Considering the close interplay between host and bacteria cell, new strategies 
can be developed by targeting host molecules and pathways essential for bacterial replication. 
Hence, the disruption of TRPML1 activity using its small molecule inhibitors in infected cells 



































Figure 5.1 Macrophages isolated from TRPML1 KO mice are defective in Salmonella 
elimination  
(A) Fluorescent images showing intracellular GFP-expressing Salmonella (green) 6 hours after 
infection in TRPML1KO macrophages and WT macrophages treated with ML-SA1, ML-SI1, 
and YM201636 compounds. Cell area is demonstrated with actin staining (B) Bone marrow 
macrophages with different treatments (similar to part (A)) were infected with Salmonella for 1 
hour and the number of intracellular bacteria was determined by colony factor unit (CFU). The 
mean of triplicates SEM is shown.  
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Figure 5.2 TRPML1 function is required for restricting Salmonella intracellular survival.   
(A) Dose dependent effect of ML-SI1 on Salmonella intracellular growth after 6 hours of 
infection. (B) Salmonella growth in macrophage cell lines with higher expression (TRPML1 
O/E) or lower expression (TRPML1 KD) of TRPML1. (C) TUBEL staining indicating cell death 








Figure 5.3 TRPML1 promotes the transition of the phagosomes from the late endosomes to 
the lysosomes.  
Macrophages were infected with Salmonella for 4 hours and then stained with Lamp-1 to label 
late endosomes and fluorescent conjugated dextran to label the lysosomes. Images represent the 
morphological criteria used to determine the percent phagolysosome formation in part (B). 
Salmonella was able to avoid fusion with lysosomes in TRPML1 KO macrophages as well as 
WT macrophages exposed to TRPML1 specific inhibitor (ML-SI1) and BAPTA-AM. (B) 





Figure 5.4 TRPML1 promotes the formation of phago-lysosomes.  
Live imaging confocal microscopy evaluating phagolysosome formation in WT macrophages 
and macrophages treated with ML-SI1 and YM 201636 compounds (0-30 miutes). White boxes 








Figure 5.5 Bacteria survival depends on intracellular and localized Ca
2+
 release. 
Dose-dependent effect of fast Ca
2+
 chealtor BAPTA-AM on Salmonella growth in WT 
macrophages. The slow Ca
2+ 
chelator EGTA-AM had no significant effect. Neither, BAPTA-AM 


















Figure 5.6 Lysosomal isolation procedures  
(A) Diagram illustrating the steps of lysosome membrane fractionation. A-G denotes major 
fractions recovered and analyzed by immunoblot analysis. (B) Cells were treated according to 
the fractionation scheme as described in the Methods and Results sections and as shown in (A). 
Cells were disrupted using a ball-bearing homogenizer and centrifuged at 4500 RPM. The 
supernatant was then loaded at the top of a discontinuous sucrose gradient and centrifuged for 1 
hour, yielding three distinct membrane layers which were used for further fractionation. After 
this step, aliquots representing equal volumes of each fraction (A–G) were subjected to 
immunoblot analysis for the indicated organelle markers. (C) The heavy membrane fraction 
obtained after the discontinuous sucrose gradient step was loaded on a continuous 8%–27% 
iodixanol gradient and centrifuged for 2.5 hours, after which fractions were collected from the 










Figure 5.7 Intralysosomal accumulation of iron induces Salmonella growth in TRPML1 
KO macrophages. 
(A) Ionic composition of the isolated lysosomes was quantified by using ICP-MS. There were no 
difference in the Iron composition of the lysosomes isolated form WT and TRPML1 KO 
macrophages. However, after treating the cells with iron-dextran overnight, there was a 
significant increase in the iron content of lysosomes isolated from TRPML1 KO macrophages 
compared to WT cells. (B) Sulphide-Silver Method (SSM) staining revealed iron accumulation 
in the lysosomes (black arrows) close to the nucleus (red arrow). (C) Intracellular Salmonella 
survival was significantly increased in TRPML1 macrophages after loading the cells with iron-
















1. Summary of results and significance  
 
Phagocytosis of large extracellular particles, such as apoptotic bodies, requires a 
substantial amount of intracellular membrane to surround and ingest the particles (Huynh, Kay et 
al. 2007). Lysosomes have been proposed as a candidate source of intracellular membranes. 
Upon particle binding to macrophage surface receptors, lysosomes have been shown to fuse with 
plasma membrane through lysosomal exocytosis to provide the excess membrane required for 
phagosome formation (Braun, Fraisier et al. 2004; Braun and Niedergang 2006; Czibener, Sherer 
et al. 2006). Here I showed that TRPML1 activation is required to mediate lysosomal exocytosis 
and fusion of lysosomes with plasma membrane in macrophages (Chapter II). Additionally, I 
identified TRPML1 on the surface of the lysosomes as the key Ca
2+
 channel regulating large 
particle uptake through the induction of lysosomal exocytosis (Chapter III) and a lysosomal 
specific phosphoinositide, PI(3,5)P2, as the channel agonist that is produced upon particle 
binding (Chapter IV). Therefore, our findings illustrate that TRPML1 represents the first Ca
2+
 
channel and the first lysosome ion channel regulating two fundamental cellular processes: 
lysosomal exocytosis and phagocytosis (Fig. 6.1). Although the role of Ca
2+
 in lysosomal 
exocytosis and phagocytosis has been well studied, it remains enigmatic and controversial 





particle uptake during phagocytosis is generally considered to be Ca
2+
-independent. Yet, 
lysosomal exocytosis has been reported to be required for phagocytosis (Braun, Fraisier et al. 
2004; Braun and Niedergang 2006; Czibener, Sherer et al. 2006; Huynh, Kay et al. 2007). One 
reason for this inconsistency could potentially be that the conventional techniques for measuring 
Ca
2+
 lack the sensitivity and resolution needed to detect the small and localized amount of Ca
2+
 
required for this process. Indeed, in our study, by using a lysosomal targeted genetically encoded 
Ca
2+
 sensor, I was able to directly observe lysosomal Ca
2+
 release during phagosome formation 
in macrophages (Fig. 3.9). Additionally, the role of Ca
2+
 in lysosomal exocytosis was suggested 
largely through the use of non-specific reagents such as the Ca
2+
 ionophore ionomycin, which 
induces Ca
2+
 flux non-physiologically and independent of any specific ion channels. Our 
identification of a lysosomal Ca
2+
 channel that regulates both lysosomal exocytosis and 
phagocytosis has provided definitive evidence at the molecular level for the roles of Ca
2+
 and 
lysosomal membranes in large particle uptake (Fig. 6.1). The Ca
2+
-dependence of exocytosis is 
well established in neurotransmitter release in which the voltage-gated Ca
2+
 channels are 
responsible for Ca
2+
 flux in response to voltage changes. I have now identified the machinery 
(TRPML1-PI(3,5)P2) for the second, but drastically different, example of the Ca
2+
-exocytosis 
link (Chapter II).  
In addition to the role of TRPML1 in large particle uptake during phagocytosis, I have 
potentially discovered another role for TRPML1 during phagosome maturation (Chapter V). I 
observed that macrophages isolated from TRPML1 KO mice are defective in restricting the 
intracellular survival of Salmonella. By using both genetic and pharmacological approaches, I 
showed that TRPML1 most likely regulates the fusion of Salmonella containing vacuoles with 
lysosomes, hence, promoting their lysosomal degradation. Therefore, my results illustrated that 
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TRPML1 mediates the fusion of lysosomes with the plasma membrane during the early stages of 
phagocytosis in addition to regulating the fusion of lysosomes with the phagosomes through 
phagosome maturation. I discuss this in more detail in the next section.  
 
2. The dual role of lysosomes during phagocytosis  
Throughout years, several different important studies have established lysosomes as the 
end point of phagocytosis where they fuse with the phagosomes through phagosomal maturation 
to aid the degradation of ingested particles (Aderem and Underhill 1999; Niedergang and 
Chavrier 2004; Flannagan, Jaumouille et al. 2012). In addition to the lysosome’s role in particle 
degradation, I have shown that during large particle uptake lysosomal membrane proteins, such 
as TRPML1, SytVII, and Lamp1, are rapidly delivered to forming phagosomes. Our data 
suggests that lysosomes play a very dynamic role during phagocytosis and they are delivered to 
phagosomes through two different stages, phagosomes formation and maturation (Chapters III & 
V).  
Throughout this study, I performed a number of live imaging experiments using a variety 
of endolysosomal or phagosomal markers (Rab5, PI3P probe, PI(3,4,5)P3/PI(3,4)P2 probe, Rab7, 
SytVII, Lamp1, and LysoTracker) in pairs with TRPML1-GFP or TRPML1-mCherry to gain 
insight into the dynamics of lysosomes during phagosome formation and maturation (Chapter III, 
IV & V). During the course of large particle uptake, I found that Rab5-GFP began to appear on 
newly formed phagosomes 5-10 minutes after phagocytosis initiation, but disappeared after 10 
minutes (Fig. 3.5). Afterwards, Rab7 appeared on phagosomes 20 min after phagosome initiation 
(Fig. 3.5), reflecting the Rab5 to Rab7 conversion/switch that is required for late phagosome 
maturation or phagosome-lysosome fusion (Henry, Hoppe et al. 2004; Kitano, Nakaya et al. 
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2008). In agreement with this time course, LysoTracker Red, a fluorescent dye that labels acidic 
organelles in live cells, also appeared on phagosomes 20 minutes after phagocytosis initiation 
(Fig. 3.5). Phagosome-lysosome fusion and phagosomal acidification are the key events during 
late phagosome maturation.  Collectively, these results suggest that in our system, consistent 
with the literature (Henry, Hoppe et al. 2004), Rab5 and Rab7 are sequentially recruited to early 
and late phagosomes, respectively, for the purpose of phagosome maturation. Interestingly, 
TRPML1, Lamp1, and SytVII were found to appear on forming phagosomes within 5 minutes 
after phagocytosis initiation, prior to Rab5 recruitment (Fig. 3.5). Although, their fluorescence 
intensity on phagosomal membranes continued to increase over the time course of the 
experiments, phagosomal acidification (LysoTracker) failed to occur until Rab7 recruitment. 
Hence, TRPML1 and Lamp1 are recruited during phagosome formation, prior to Rab5-mediated 
early phagosome maturation. To further separate these two processes (phagosome formation and 
maturation), I monitored the TRPML1-GFP recruitment in macrophages that were exposed to 
small particles. In contrast to large particle uptake, TRPML1-GFP was recruited only after 20 
minutes of phagocytosis initiation in small particle uptake (Fig. 3.5).  
Strikingly, the early recruitment of Lamp1 to the forming large phagosomes was 
significantly blocked in TRPML1 KO cells (Fig. 3.6). These results suggest that the only role 
that can be attributed to TRPML1-mediated lysosomal exocytosis is Lamp1 recruitment. In 
connection with this, in chapter V I showed that in macrophages isolated from TRPML1 KO 
mice the fusion of late endosomes containing Salmonella was blocked, as revealed when using 
fluorescent conjugated dextran. This suggests TRPML1 also mediates the fusion of late 
endosomes with lysosomes late in the phagosomal maturation process (Fig. 5.3)  
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Collectively, these data suggest that lysosomes are delivered to the phagosomes at two 
different stages (Fig. 6.2). First, for large particles, lysosomes fuse with the plasma membrane at 
the phagocytic cup, which provides the membranes necessary for phagosome formation. As a 
result, lysosomal membrane proteins, such as TRPML1 and Lamp1, are delivered to the newly 
formed phagosomes, prior to or during phagocytic cup closing. This is an indirect (through 
lysosomal exocytosis) path that occurs early during phagosome formation (Fig. 6.2). Second, for 
both large and small particles, lysosomes are delivered to the late phagosomes through late 
phagosome maturation (phagosome-lysosome fusion), which is required for the degradation of 
phagocytic materials. This second stage is accompanied by Rab7 recruitment and phagosomal 
acidification, as well as further recruitment of lysosomal membrane proteins including TRPML1 
and Lamp1. This is a direct path that occurs late during phagosome-lysosome fusion (Fig. 6.2). 
As discussed in previous studies (Czibener, Sherer et al. 2006), the early recruitment of 
lysosomal membrane proteins may serve as an early preparation of phagosome maturation, but is 
not essential for phagosome maturation.  
 
3. TRPML1 induced lysosomal exocytosis as a therapeutic approach for LSDs. 
 
Accumulation of lipids in lysosomes has been associated with several human diseases 
(LSDs, Chapter I). Identification of molecules and processes that could clear the accumulated 
materials can potentially serve as a novel therapeutic target for LSDs. Several therapeutic 
approaches have been developed for LSDs including substrate reduction therapy, bone-marrow 
transplantation, gene therapy, and enzyme replacement therapy (ERT) (Cox and Cachon-
Gonzalez 2012). ERT and substrate reduction are the most common therapies, especially for the 
treatment of Gaucher and Fabry diseases (Eng, Banikazemi et al. 2001; Cox and Cachon-
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Gonzalez 2012). In addition, for a subset of mutation causing Gaucher, Fabry, and Tay-sachs 
diseases that are caused by enzyme misfolding in the ER, chemical chaperones have been proven 
helpful (Sawkar, Adamski-Werner et al. 2005).  For most LSDs, however, an effective 
therapeutic approach is still lacking. For the currently available approaches, there are various 
intrinsic limitations, especially the problem of low efficacy.  For instance, while the brain is the 
most commonly affected tissue in LSDs, it is very difficult in ERT to deliver enzymes across the 
blood-brain barrier.  Most importantly, all the current available approaches are disease specific. 
There are many different conditions characterized as LSDs resulting from dysfunction of 
different lysosomal proteins, so developing disease specific therapies could be extremely 
expensive. Most evidence illustrates many similarities between the mechanisms that lead to lipid 
storage diseases, suggesting that a common approach targeting specific pathways can potentially 
rescue the disease phenotype (Schultz, Tecedor et al. 2011). For instance, one similar 
observation in almost all LSDs is that the dysfunction of the disease associated enzyme is 
correlated with an increase in expression or activity of other lysosomal proteins such as Lamp-1 
(Ballabio and Gieselmann 2009; Schultz, Tecedor et al. 2011). This suggests that the expression 
of lysosomal proteins are interconnected and related to each other. So it is possible that a 
common process regulating lysosomal function could also be defected in lipid storage diseases 
and targeting that common process could potentially be a universal therapeutic strategy.   
The discovery of TFEB made this approach very appealing (Chapter I) (Sardiello and 
Ballabio 2009; Sardiello, Palmieri et al. 2009). Interestingly, the overexpression of TFEB 
enhanced the clearance of storage materials in several LSDs such as multiple sulfatase deficiency 
(MSD), mucopolysaccharidosis type IIIA (MPS-IIIA) , Batten, and Pompe’s disease (Medina, 
Fraldi et al. 2011; Settembre, Fraldi et al. 2013; Spampanato, Feeney et al. 2013). Notably, 
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TFEB overexpression in all these assays reduced lysosomal storage in different LSDs despite the 
lack of function of the disease specific lysosomal enzyme, so it is not unforeseen that TFEB can 
also be used to decrease the storage of lipids within the lysosomes in other LSDs.  
 The beneficial effect of TFEB on various LSDs is dependent on TRPML1 and lysosomal 
exocytosis (Medina, Fraldi et al. 2011).  TFEB-mediated clearance is largely abolished when 
TRPML1 channel activity is compromised or when lysosomal exocytosis is inhibited (Medina, 
Fraldi et al. 2011). Additionally, unlike other LSDs, the overexpression of TFEB failed to induce 
the clearance of stored materials in MLIV cells, indicating that TFEB most likely induces 
cellular clearance through the activation of TRPML1 (Medina, Fraldi et al. 2011). Considering 
that TRPML1 is up-regulated by TFEB overexpression (Sardiello, Palmieri et al. 2009), it is 
likely TFEB may directly up-regulate TRPML1 to promote lysosomal exocytosis.  However, 
TFEB may also mediate the expression of Vac14 (Sardiello, Palmieri et al. 2009), a protein 
required for PI(3,5)P2 production (Chapter IV) (Duex, Tang et al. 2006).  Therefore, it is possible 
that TFEB promotes substrate clearance in different LSDs by increasing the expression/function 
of TRPML1 (Fig. 6.3). In agreement with this, TRPML1 overexpression and small molecule 
TRPML1 agonists were shown to promote cholesterol clearance in NPC cells (Shen, Wang et al. 
2012).  As cholesterol accumulation is commonly seen in many LSDs, “activating” TRPML1 
may represent a novel therapeutic approach for many other LSDs (Fig. 6.3).  As I shown in 
Chapter II, TRPML-specific agonist ML-SA1 can induce lysosomal exocytosis in macrophages. 
Thus, ML-SA1 together with the next generation of TRPML-specific activators may be used as a 





4. The role of TRPML1 in phagocytic clearance and neurodegeneration.  
One of the interesting defects seen in most of the animal models of  LSDs (Chapter I) is the 
massive amount of inflammatory responses in the brain (Jeyakumar, Dwek et al. 2005) that is usually 
initiated by microglia and macrophages in the innate immune system. These types of inflammatory 
responses are also seen in common neurodegenerative disease such as Alzheimer’s (McGeer and 
McGeer 2003) and Parkinson’s diseases (McGeer and McGeer 2004). This indicates that LSDs, as 
well as other common neurodegenerative diseases, share similar pathological cascades and 
molecular pathways.  
It is not clear what triggers the enormous inflammatory response in the brain of animal 
with LSDs. As explained in chapter I, LSDs are usually characterized by the accumulation of 
undigested lipids in the lysosomes (Fig. 1.1&1.2). These storage materials are structurally 
normal self-components and should be immunologically silent. However, lipid accumulation 
leads to the activation of resident microglia and recruited macrophages in the brain which initiate 
an inflammatory response. How macrophages and microglia are initially activated in response to 
lipid accumulation in their lysosomes remains unknown. One of the main triggers to initiate an 
inflammatory response by microglia/macrophages may be the clearance of apoptotic neurons 
through phagocytosis. Phagocytic clearance in the brain is strongly related to the homeostatic 
maintenance of the brain. Both microglia and macrophages act as the “garbage trucks” of the 
brain as they regulate the physical removal of dying cells. This usually occurs quickly and 
includes the recruitment of the microglia/macrophages to the site of apoptotic cell accumulation 
and the activation of phagocytosis process by the binding of the apoptotic cells to the surface 
receptors of the microglia/macrophages. This leads to the clearance of the dying cells and 
prevents the release of toxic or immunogenic intracellular content from the dying cell into the 
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extracellular space which can contribute to the inflammation responses. In addition, activated 
microglia themselves also produce pro-inflammatory compounds that can induce an 
inflammatory response in the brain. Therefore, the accumulation of both activated microglia and 
apoptotic cells in the brain collectively induces substantial inflammation in the brain.  
  How does lipid accumulation in the lysosomes of the microglia lead to inflammation?  I 
showed that in macrophages isolated from mouse models of two different LSDs, MLIV and 
Charcot-Marie-Tooth (CMT/ALS) diseases (which is caused by deficiency in PI(3,5)P2 
production), the uptake of large particle phagocytosis, which resemble apoptotic cells in size, 
was severely impaired. Consistently, microglia activation was evident in the brains of these mice 
as well as in the mouse models of other LSDs (Jeyakumar, Dwek et al. 2005). So it is possible 
that TRPML1 mediated lysosomal exocytosis contributes to microglia activation and the 
clearance of apoptotic debris in the brain (Fig. 6.4). For example, in the Drosophila model of 
MLIV, it is proposed that the defective clearance of late apoptotic neurons contributes 
significantly to neurodegeneration (Venkatachalam, Long et al. 2008). Thus, this could be the 
basic phagocytic mechanism that could explain pathogenic accumulation of apoptotic cells and 
brain inflammation seen in most LSDs and it could demonstrates the first mechanistic link 
between lysosome storage and inflammatory response. Therefore, the activation of TRPML1 
could potentially serve as a therapeutic target for the activation of the phagocytic clearance of 
microglia/macrophages in the brain and other tissues across the body. This remains to be 
investigated by evaluating the particle uptake efficiency of microglia/macrophages isolated from 
















Figure 6.1 Defects in TRPML1function leads to decrease lysosomal exocytosis and defective 
clearance of apoptotic bodies in different tissues. 
Dysfunction of TRPML1, either by genetic manipulations or by lacking its endogenous activator 
PI(3,5)P2, leads to decrease in lysosomal Ca
2+
 release and subsequent inhibition of lysosomal 
exocytosis. This leads to defective phagocytic clearance by macrophage/microglia cells which 
can have several different consequences such as iron deficiency and overload in the spleen 
and/or the accumulation of apoptotic neurons and microglia activation in the brain. All these can 














Figure 6.2 The dual role of lysosomes during phagocytosis.  
Particle binding activates lysosomal TRPML1 to initiate Ca
2+
-dependent lysosomal exocytosis.  
Upon particle (IgG-RBC) binding, the activity of PIKfyve (not shown) is stimulated at the site of 
particle uptake.  The subsequent increase of PI(3,5)P2 level can then activate lysosomal 
TRPML1 to induce lysosomal Ca
2+
 release.  Juxtaorganellar Ca
2+
 can then bind the Ca
2+
 sensor 
SytVII to trigger lysosome-plasma membrane fusion, which provides substantial amount of 
lysosomal membranes for the pseudopod extension around IgG-RBCs.  As a result, lysosomal 
membrane proteins, such as TRPML1 and SytVII, are inserted into the plasma membrane.  
Pseudopod extension continues until the IgG-RBCs are completely internalized.  Phagocytic 
cups are then closed, and nascent phagosomes are formed.  Newly formed phagosomes then 
undergo a series of membrane fusion and fission processes, collectively called phagosome 
maturation, to become late phagosomes.  Lysosomes are also delivered to the late phagosomes 
through late phagosome maturation (phagosome-lysosome fusion), which is required for the 






Figure 6.3  Cellular clearance by TFEB and TRPML1-mediated lysosomal exocytosis.  
 
Accumulation of undigested lipids and other materials cause LSDs.  Lysosomal exocytosis 
promotes cellular clearance in LSDs regardless of the primary defects and nature of the 
accumulated materials.  The lysosome biogenesis transcription factor TFEB increases lysosomal 
docking and up-regulates the expression and/or activity of lysosomal Ca
2+
 channel TRPML1.  
Activation of TRPML1 by small molecule synthetic agonists induces lysosomal fusion with the 
plasma membrane.  Increasing the activity and expression of TFEB and TRPML1 promote 
lysosomal exocytosis to induce the clearance of lysosome storage, serving as a potential 












Fig 6.4 TRPML1 induced phagocytic clearance is required to avoid inflammation in LSDs 
Under normal conditions apoptotic cells are ingested and eliminated by phagocytic cells, such as 
microglia, in the brain. Once apoptotic cells interact with the receptors on the surface of the 
macrophages (not shown) they trigger a series of events that lead to the induction of 
phagocytosis, including the activation of TRPML1 on the surface of the lysosomes that leads to 
the recruitment and fusion of lysosomes with the plasma membrane to provide excess membrane 
for pseudopods formation and particle ingestion.  However, lack of TRPML1 activity results in 
insufficient particle ingestion in activated microglia which results in the accumulation of 
apoptotic cells in the brain. Accumulated apoptotic cells along with activated microglia produce 
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